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Chemotherapy
ABSTRACT
Chemotherapy is a concept that strikes a chord inside many people, conjuring
images of nausea, hair loss, and pain. It is synonymous with cancer. The impact of
undergoing treatment for a life-threatening diagnosis like cancer can have both seen and
unseen impacts on the person, their families, and their loved ones. The effects can
reverberate through a person’s life, affecting not only their health status, but also their
relationships, careers, sense of self, worldview, and spirituality. This study looks more
closely at the experiences of women who have undergone chemotherapy for the treatment
of breast cancer and considers the full range of experiences to better understand the
effects it has on people’s lives. Specifically, the purpose of this study is to lay the
groundwork for the understanding of the impact of chemotherapy on breast cancer
survivors. Through 11 one-to-one interviews with women who have been treated with
chemotherapy for breast cancer, this study will focus in-depth on what the experience of
chemotherapy was like for these women and how it changed their lives.
Major findings in this study include significant experiences of positive life
changes in the realms of sense of self, relationships, and spirituality following
chemotherapy. This study can be broadened to include people undergoing many different
invasive treatment procedures and affect how mental health professionals interact with
and treat these populations.
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CHAPTER I
INTRODUCTION
Chemotherapy is a concept that strikes a chord inside many people, conjuring
images of nausea, hair loss, and pain. It is synonymous with cancer. The impact of
undergoing treatment for a life-threatening diagnosis like cancer can have both seen and
unseen impacts on the person, their families, and their loved ones. The effects can
reverberate through a person’s life, affecting not only their health status, but also their
relationships, careers, sense of self, worldview, and spirituality. When chemotherapy is
chosen as a method of treatment, this impacts the person’s experience of the illness as it
can cause a myriad of side effects that range from mild to life threatening, in and of
themselves. These can lead to an array of responses that range from mild discomfort to
symptoms of trauma (Stewart, Bielajew, Collins, Parkinson, and Tomiak, 2006, Mehnert
and Koch, 2007, and Rabin, Leventhal, and Goodin, 2004). For many, chemotherapy
changes the landscapes of their lives and is often regarded as being worse than the cancer
(Docherty, Sandelowski, and Preisser, 2006). The DSM-IV-TR includes “being
diagnosed with a life-threatening illness” as a traumatic event that can lead to the
symptoms and diagnosis of Posttraumatic Stress Disorder (PTSD) (DSM-IV-TR, 2000, p.
462). This study proposes to closely examine the specific stressors that can arise from
chemotherapy as it is considered independently from cancer. Previous research has found
that individuals undergoing chemotherapy experience changes in quality of life (e.g.
Zebrack, Yi, Petersen, and Ganz, 2007, Hurria, A., Rosen, Hudis, Zuckerman, Panageas,
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Lachs, Witmer, van Gorp, Fornier, D’Andrea, Moasser, Dang, Van Poznak, Hurria, and
Holland, 2006, and Carver, Smith, Petronis, and Antoni, 2006), anticipatory nausea (e.g.
Montgomery, Bovbjerg, 2003, and Montgomery,Bovbjerg, 2001), cognitive impairment
(e.g. Falleti, Sanfilippo, Maruff, Weih, and Phillips, 2005, and Bender, Sereika, Berga,
Vogel, Brufsky, Paraska, and Ryan, 2006), depression and anxiety (e.g. Reddick, Nanda,
Campbell, Ryman, and Gaston-Johansson, 2005, and Deshields, Tibbs, Fan, and Taylor,
2006), and fatigue (e.g. Jacobsen, Hann, Azzarello, Horton, Balducci, and Lyman, 1999,
and Mills, Parker, Dimsdale, Sadler, and Ancoli-Israel, 2005). None of these studies,
however, have looked at how these chemotherapy side effects have affected the realms of
spirituality, sense of self, and worldview as this study does.
What is it like when the treatment for the illness is what many consider to be the
worst part? What about effects that aren’t considered to be traumatic, but still impact
one’s life? This study looks more closely at the experiences of women who have
undergone chemotherapy for the treatment of breast cancer and considers the full range
of experiences to better understand the effects it has on people’s lives. Specifically, the
purpose of this study is to lay the groundwork for the understanding of the impact of
chemotherapy on breast cancer survivors. However, the implications of the findings of
this study can be broadened and generalized to other cancers that have a chemotherapy
protocol as well. These findings can be translated into ways to provide more emotional,
physical, spiritual, and mental support for patients undergoing chemotherapy and allow
for a better understanding of what happens when someone undergoes a life-threatening
treatment. While the chemotherapy experience may not be explicitly traumatic, it is
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possible that it is on a spectrum that includes its own set of psychologically distressing
symptoms that need to be addressed in the field of mental health.
Through one-to-one interviews with women who have been treated for breast
cancer, this study will focus in-depth on what the experience of chemotherapy was like
for these women and how it changed their lives, for good, bad, or not at all. This kind of
information can lead to a better understanding of what is needed by cancer patients
before, during, and after chemotherapy. Are their mental health needs being met? Are
their relationships being strained? Has it raised questions regarding their faith? Do they
regret the decision? All of these are important factors to consider when treating a person
as a whole and should not be overlooked by the medical and mental health communities.
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CHAPTER II
LITERATURE REVIEW
A 2006 case study examined the reactions of a teenage girl, Abby, undergoing
chemotherapy for the treatment of Hodgkin’s Lymphoma (Docherty, Sandelowski, and
Preisser, 2006). What the authors observed was the young woman “fighting the
treatment, as opposed to fighting the cancer. (Her) response to her symptoms frightened
her, and she felt that she might not be up to the challenge” (Docherty et al., 2006, p.305).
Abby wrote in her journal “(w)ell, it’s a feeling that I had for awhile with this. It didn’t
seem right. It just didn’t make any sense to me that for my body to get better, I have to
completely break it down and get sick and just, and just so I can get better. It just didn’t
seem right” (Docherty et al., 2006, p.304). In a 1997 case study, Flemons followed a
woman, Judith Shulimson, through her treatment for breast cancer and included segments
from her journal in his case study. She wrote that “(t)he cure is worse than the disease,
especially since the disease hasn’t really caused me any problems so far; it’s the
treatment that has made me so sick….The first chance I get to think about continuing
with chemotherapy I start thinking of running away….Chemotherapy: metaphors of
aggression, destruction, violence, warfare” (Flemons and Shulimson, 1997, p.182). The
irony of the cure being worse than the disease is hardly a novel idea and is certainly not
limited to chemotherapy. Around 100 BC, Greek philosopher Publilius Syrus stated that
“(t)here are some remedies worse than the disease.” This idea seems to be especially
highlighted in the use of chemotherapy to treat cancer. The side effects can result in
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myriad changes that people may experience for the rest of their lives, or at least long after
treatment for their cancer has ended. For women with breast cancer this can be especially
poignant as they are already wrestling with a sickness that has struck in a place that, for
many, is an important part of their identity and sexuality. When chemotherapy ends it
does not necessarily denote the end of its impact.
Co-Morbids
Multiple studies have found that chemotherapy has been associated with high comorbidities of both a physical and psychological nature (Maguire, Faulkner, Booth,
Elliot, and Hillier, 1996, Wilkinson, 1991, and Watson, Meyer, Thomson, and Osofsky,
1998). The psychological co-morbidities looked at in this study are Posttraumatic Stress
Disorder, Anxiety Disorders, and Depression, as well as general feelings of lowered
emotional and affective functioning caused by side effects.
Posttraumatic stress disorder (PTSD)
The DSM-IV-TR explains PTSD, in part, as the development of certain
“symptoms following exposure to an extreme traumatic stressor involving direct personal
experience of an event that involves actual or threatened death or serious injury, or a
threat to one’s physical integrity” (American Psychiatric Association (APA), 2000,
p.463). It goes on to include “being diagnosed with a life-threatening illness” (APA,
2000, p.464) as one of these traumatic stressors. With these criteria in mind,
chemotherapy certainly seems to fit this bill, as well as the diagnosis of cancer itself.
With its dramatic side effects and reputation for being worse than the cancer,
chemotherapy appears to fit the bill of being a “traumatic stressor” (APA, 2000, p.463).
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Much of the current research regarding PTSD symptoms and breast cancer is
focused on the diagnosis (Tjemsland, Soreide, & Malt, 1996) or the overall experience
itself (Rabin, Leventhal, & Goodin, 2004, Mehnert & Koch, 2007, and Amir & Ramati,
2002). Much of the findings from these studies highlight the fact that “(t)here is evidence
that a number of patients develop cancer- or treatment-related PTSD” (Mehnert & Koch,
2007, p.186). However, the findings also supported the strong link between patients’
understandings about the cancer and the treatment and subsequent symptoms of PTSD.
According to Rabin et al. (2004), the emotional reactions of most patients to their illness
are due in large part to their beliefs about the disease, not medical information. This
underscores the importance of a patient’s state of mind and beliefs while undergoing
chemotherapy in determining how the treatment will effect them post-treatment. Amir
and Ramati (2002) found a correlation between women receiving chemotherapy with a
low-disease stage and a higher risk for developing PTSD-like symptoms. A possible
theory behind their finding is “that the coping style of suppression in a supposedly
healthy woman (low disease stage), combined with difficult chemotherapy, creates the
most fertile ground for the development of PTSD symptoms” (Amir & Ramati, 2002,
p.204) thus underscoring the profound impact of chemotherapy and the associated beliefs
a patient may have with it in determining its long-term effects in survivors.
Taieb, Moro, Baubet, Revah-Levy, and Flament (2003) looked at PTSD
symptoms in young survivors of childhood cancer and their parents. They found that “it
is both the diagnosis of cancer (an acute event of life threat) and its treatment (a longlasting or repetitive threat to both life and physical integrity), which are experienced as
the traumatic events by children and their parents” (Taieb et al., 2003, p.262).
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Tjemsland et al. (1996) conducted a study in which they focused solely on the
experience of being diagnosed with breast cancer and the time leading up to initial
surgery. They found that “nearly half of the patients reported a high level of intrusive
thoughts during the days immediately following diagnosis” (Tjemsland et al., 1996, p.6).
Could some of these intrusive thoughts be related to anticipation anxiety for what the
patients may assume to be a treatment protocol that may include chemotherapy?
Certainly it’s hard to separate the concept of cancer from its most high-profile treatment.
Psychological distress including depression, anxiety, and cognitive functioning
Several studies have cited psychological distress (including depression, anxiety,
emotional expression, and neuropsychological effects) as a phenomenon commonly
associated with breast cancer and its treatment. Pieterse, van Dooren, Seynaeve, Bartels,
Rijnsburger, de Koning, Klijn, van Elderen, Tibben, & Duivenvoorden (2007) related
coping styles with psychological distress measurements. They found that “(a)pproach
coping (trying to do something about the stressor) for instance, was found to be more
beneficial than avoidant coping (trying to avoid the stressor)” (Pieterse et al., 2007,
p.851). Moreover, Pieterse et al. found that when a patient either sought out, or had in
place, strong social support this could decrease levels of psychological distress and was
in line with the results associated with active coping styles. A study by Manne,
Glassman, and Du Hamel (2000) found that a decline in physical abilities in women with
cancer predicted maladaptive coping strategies more often in those with lower-stage
cancer than those with a higher stage. This would seem to imply that the psychological
distress experienced by healthier seeming women is greater and more drastic than that of
women who may be sicker. Reddick, Nanda, Campbell, Ryman, & Gaston-Johansson
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(2005) had findings that were consistent with this hypothesis and also found that “coping
plays a significant role in the process of psychosocial adaptation to breast cancer”
(Reddick et al., 2005, p.151). Again, this underscores the connection between the impact
of cancer and chemotherapy and women’s self-views. It also speaks to the idea that
women with better coping strategies may find that previously held personal beliefs are
less affected by treatment. Shapiro, Boggs, Rodrigue, Urry, Algina, Hellman, and Ewen
(1996) studied differences in various coping styles and found that side effects were less
profound in women with a confrontive coping style, that is, women who sought out
information and were willing to talk about cancer both in and out of the treatment setting,
as well as women who reported higher levels of optimism. “(C)oping patterns were
significant predictors of physical, psychological, and total side effects in women with
stage II breast cancer receiving adjuvant chemotherapy” (Shapiro et al., 1996, p.152). As
to optimism having an effect on lone-term psychological well-being, Tartaro, Roberts,
Nosarti, Crayford, Luecken, and David (2005) wanted to know what consequences and
outcomes, if any, women saw who were able to find some benefit in their course of
illness and treatment. What they found in this study was that prior to diagnosis, while
seeking treatment for their symptoms, the women who reported higher levels of distress
were the same women who were able to find benefit in their cancer and treatment
experience, thus plummeting their distress scores during their course of treatment.
However, two-and-a-half years following the end of treatment, women who had found
benefit and women who had not, were equal in levels of distress in quality of life (QOL)
and adjustment. One notable difference was that spiritual well-being was reported as
higher by the women who felt they had found some meaning in their cancer than those
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who did not (Tartaro et al., 2005). Whether this is caused by the cancer diagnosis alone,
or is on part due to the course of chemotherapy, is what this study aims to look at.
Lam, Chan, Ka, and Fielding (2007) looked at treatment decisions made postsurgery by Chinese women and found that those who had difficulties deciding on a
course of treatment, and had experienced distress during the early post-operative period,
“were at greater risk of persistent psychological morbidity” (Lam et al., 2007, p.910).
“(P)sychological morbidity is not just a transient reaction to diagnosis and treatment of
breast cancer, with 49% reporting psychological morbidity lasting at least 8-months”
(Lam et al., 2007, p.910). This statistic, when compared with the rate of psychological
morbidity in Caucasian women, was significantly higher. Interestingly enough, the
authors noted that this discrepancy may have more to do with the younger average age of
their participants, 51.2, than with their ethnicity, as they were being compared to women
in western studies with the average age of 59.4. This correlates with studies about
younger women having more adverse reactions to chemotherapy, as discussed in a later
section.
While depression is not a statistically likely response to breast cancer treatment,
when it is a factor it can have over-arching consequences that can lower perceived QOL
(Deshields, Tibbs, Fan, & Taylor, 2006). “Depressive symptoms can affect interpersonal
relationships, occupational performance, perceptions of health, and physical symptoms”
(Deshields et al., 2006, p.404). According to other studies, a third of people with cancer
will develop a depressive illness and/or an anxiety disorder (Derogatis, Morrow, Fetting,
Penman, Piasetsky, and Schmale, 1983, and Parle, Jones, and Maguire, 1996). As cited in
Chan, Ho, and Chan (2007), “Zebrack concluded that ‘quality of life outcomes partially
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may be a function of the cognitive frame or meaning that survivors attribute to their
experience’” (Chan et al., 1999, p.847). Certainly, if a person is suffering from depressive
symptoms this framework would be significantly affected and thus their feelings
regarding identity and self-view, among other things. In a study comparing depressive
symptoms immediately following treatment and again 2 years after diagnosis, Sharpley
and Christie (2007) found that women’s initial self-reports were higher than those
subsequent. “(T)hey placed less weight upon the somatic symptoms as time went by and
instead emphasized more their lack of ability to cope with demands of having cancer,
their mental confusion and their feelings of hopelessness and loss of previously valued
activities” (Sharpley & Christie, 2007, pps.759-760). This finding begs the question
about how many of these symptoms were due to anxiety and fear proceeding the start of
chemotherapy and then morphed into concerns about quality of life and loss of cognitive
functioning following the end of treatment.
A meta-analysis of studies conducted by Stewart, Bielajew, Collins, Parkinson,
and Tomiak (2006) found significant results linking cognitive decline with adjuvant
chemotherapy for breast cancer. “It has been suggested that these changes are a
consequence of chemotherapy-related neurotoxicity” (Stewart et al., 2006, p.77). In this
study a decline in visual memory, attention, visuospatial functioning, learning, speed of
processing, and verbal learning were linked with women who had undergone
chemotherapy for the treatment of their breast cancer (Stewart et al.). A meta-analysis of
six studies on the subject found that “chemotherapy may give rise to some generalized
cognitive impairment” (Falleti, Sanfilippo, Maruff, Weih, & Phillips, 2005, p.66). Yet
another study also found declines in verbal memory but not visual memory, however, this

10

study also found that “perceptions of cognitive impairments were evident immediately
following the conclusion of chemotherapy. Thus, the subjective reports of cognitive
impairment preceded declines detected by the objective measures” (Bender, Sereika,
Berga, Vogel, Brufsky, Paraska, & Ryan, 2006, p.428). A perceived cognitive decline
that occurs before an objectively measurable one could be argued to be due, at least in
part, to previously held beliefs about chemotherapy and its side effects as understood in
our culture. Such beliefs could weigh heavily in the impact such a treatment has. One
could speculate that any deterioration in such significant areas of cognitive functioning
would most assuredly have some impact on a patient’s sense of identity.
A study by Farrell, Heaven, Beaver, and Maguire (2005) looked at women
undergoing in-patient chemotherapy and how responsive their caregivers were to their
needs, including psychological needs. They found that nurses in the ward identified about
20% of the actual concerns of patients and “were least likely to identify concerns about
the future and psychological concerns” (Farrell et al., 2005, p.74). This is an interesting
phenomenon in that it may have a profound effect on a woman’s experience of
chemotherapy if she feels that her caregivers are not in-tune with many of her needs. If
psychological needs go unaddressed in treatment, such as feelings of sadness or anxiety,
then it can’t be assumed that they will go away once treatment is concluded and not
remain as an ongoing concern.
A study by Alder and Bitzer (2003) looked at which stages of treatment women
experienced positively and which were more negative. The stages were broken down into
diagnosis, in-patient treatment, chemotherapy, radiotherapy, and after-care and the survey
was given to women who were within 5 years of being diagnosed with breast cancer.
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What they found was that “the first diagnostic phase and the phase of chemotherapy
represented the most strainful” (Alder & Bitzer, 2003, p.93). They found that the
significance of patients having a negative experience during chemo- or radiotherapy had
higher depression and anxiety scores at the time of the survey. Women who reported
having had an overall negative experience with the medical system also showed higher
anxiety and depression scores (Alder & Bitzer, 2003). The implications of this study
suggest that a possibly mitigating influence during chemotherapy could be the
interactions with healthcare workers. It is possible that these types of encounters could
help ease feelings of anxiety and depression brought on by the side effects and
psychological impact of undergoing chemotherapy, thus making its impact less profound.
Last to note, “(l)iving through the cancer of a close family member…could
contribute to a learning history that vividly equates cancer with extremely noxious
outcomes. This could leave women in a heightened state of fear and anxiety over the
consequences of personally experiencing cancer” (Badger, Segrin, Meek, Lopez, &
Bonham, 2005, p.96). Is it the cancer itself, the fears related to treatment, or a
combination of both that create these “noxious outcomes”?
Nausea
Perhaps one of the most common side effects traditionally associated with
chemotherapy is nausea. Anticipatory nausea has been studied (Montgomery & Bovbjerg,
1996) to determine factors associated with expectations of nausea, time nausea begins in
relation to infusion, and change in pattern as treatment progresses. Results indicate that as
patients progress in their treatment their anticipatory nausea becomes based on real-life
experience of it and not just previously held beliefs (Montgomery & Bovbjerg, 2001). A
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third study by Montgomery and Bovbjerg (2003) showed a correlation between
emotional distress and anticipatory nausea before the first infusion and with no prior
history of receiving chemotherapy. The fact that anticipatory nausea can happen even
before the first infusion of chemotherapy goes to show how deeply ingrained in our
cultural awareness this side effect is and raises questions about how this affects a
patient’s overall experience of the treatment and their own role within it.
It’s not only anticipatory nausea that is a side effect of chemotherapy, but delayed
nausea as well. “(D)elayed nausea and vomiting (i.e. nausea and vomiting occurring more
than 24 h post-chemotherapy) was a considerable problem. Delayed nausea was present
for 5 days and vomiting for 3 days post-chemotherapy” (Molassiotis, 2000, p.233). Such
an intense side effect is not without its consequences, especially when considered in the
context of receiving multiple infusions over the course of treatment.
Fatigue
Similar to nausea, fatigue is one of the most common side effects experienced by
people undergoing chemotherapy. According to Servaes, Verhagen, and Bleijenberg
(2002) it is, in fact, the most common side effect. Bovbjerg, Montgomery, and Raptis
(2005) considered whether or not fatigue could be considered to be a conditioned
response to chemotherapy. Their results indicate that there is a significant relationship
between the two, even going so far as to speculate that the results may last well past the
end of treatment. As Cameron, Cella, Herndon, Kornblith, Zuckerman, Henderson,
Weiss, Cooper, Silver, Leone, Canellos, Peterson, and Holland (2001) found, it’s not
uncommon for patients to re-experience nausea when returning to the clinic long after
their treatment has ended. Another notable effect of this possibly conditioned response,
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similar to the data on nausea, is that of anticipatory fatigue (Bovbjerg et al., 2005). As
with anticipatory nausea, the researchers in this study noted a certain number of subjects
that appeared to suffer from fatigue before even their first infusion of chemotherapy.
Considering the possible psychological impact of a conditioned response of either nausea
or fatigue, or both, it is significant to note that sometimes the symptom occurs before the
stimulus has even been introduced. Can it be that the possible side effects of
chemotherapy are so commonly known that they can actually happen when
chemotherapy is just anticipated? This would seem to indicate a rather strong reaction to
the treatment, outside of its physical effects. A third common side effect, stress, has also
been studied as an anticipatory phenomenon (Lekander, 2001). “The present pattern of
data indicates that immune variables change as a function of anticipation when cancer
patients report to the treatment-associated milieu” (Lekander, 2001, p.36). Lekander goes
on to speculate that this reaction can be due to either the conditioned response, or, in the
case of patients who have yet to undergo their first infusion, “higher mental functions”
(Lekander, 2001, p.37). If the stimulus is coming from the patient’s imagination, than it is
a powerful force, indeed.
This finding proves to be even more significant in light of the research by Mills,
Parker, Dimsdale, Sadler, and Ancoli-Israel (2005) who found that “the increased ratings
of depressed mood in response to chemotherapy were best predicted by pre-treatment
ratings of depressed mood and by fatigue in response to chemotherapy” (Mills et al.,
2005, p.92). Anticipatory responses have the potential to have a great impact on posttreatment reactions. When fatigue is elevated, women tended to report that it “interfered
to a greater extent with their general activity, ability to bathe and dress, normal work
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activity, ability to concentrate, relations with others, enjoyment of life, and mood”
(Jacobsen, Hann, Azzarello, Horton, Balducci, and Lyman, 1999, p.239). Alterations to
one’s lifestyle of this magnitude, from a combination of real and perceived possible side
effects, have the potential to drastically impact many beliefs held by the person
experiencing them. Self-view, identity, sexual identity, and spirituality are all likely to be
considered during such a painful period.
Quality of Life/Identity
Quality of life
Quality of life (QOL) includes such realms as physical and emotional functioning
and health, social functioning, vitality, sleep quality (Stein, Jacobsen, Hann, Greenberg,
and Lyman, 2000), body image, future perspective, and sexual functioning/enjoyment
(Janz, Mujahid, Lantz, Fagerlin, Salem, Morrow, Deapen, and Katz, 2005) among other
things. Irwin, Arnold, Whelan, Reyno, and Cranton (1999) found in their research on
subjects who got to choose between a more aggressive and shorter course of
chemotherapy versus a longer course with fewer side effects, that “quality of life is
subjective and can only be defined by the individual based upon what he/she believes
matters most” (Irwin et al., 1999, p.290). There have been many studies on the realm of
how disease affects people’s perceived quality of life, particularly in breast cancer
research. This research relates to the current study in that the specific role that
chemotherapy plays in that process is being examined. It is interesting to note that many
of the following studies show an initial decrease in QOL during treatment, and a return to
previous levels in the months following treatment completion.
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In a study by Buick, Petrie, Booth, Probert, Benjamin, and Harvey (2000), the
researchers sought to compare the change in affect and function between women referred
for chemotherapy and those referred for radiotherapy for breast cancer. What they found
is that “(r)adiotherapy and chemotherapy produce low to moderate psychological distress
and functional impairment” (Buick et al., 2000, p.54). However, when the two groups
were directly impaired, they found that the women referred for chemotherapy
experienced more functional impairment and negative affect than did those referred for
radiotherapy, as well as more disturbance to their sleep and managing within the home.
Overall, they found that “(r)eferral for chemotherapy as opposed to radiotherapy appears
to produce an 8% to 25% increase in impairment of everyday activities” (Buick et al.,
2000, p.55). In other words, before treatment has even begun, many women experience a
negative daily impact in their lives for just having been referred for chemotherapy. The
final factor these researchers considered was the impact of the side effects of
chemotherapy on subjects’ affect and functioning levels. Hair loss, bladder infections,
and nausea “are not conducive to maintaining one’s social, vocational, and domestic
responsibilities and interpersonal relationships. Psychosocial disruption associated with
chemotherapy may affect patients’ perception of their ability to meet role demands and
personal expectations” (Buick et al., 2000, p.56). This shift in perception has the potential
to greatly affect a person’s sense of mastery and autonomy, and thus their overall selfimage. The ways in which a woman copes with these stressors could be integral for how
she feels about herself when treatment is completed.
One side effect of chemotherapy in particular, hot flashes, has been estimated to
occur in about 40% of women in chemotherapy treatment for breast cancer (Stein et al.,
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2000). Stein et al. also found that 58% of those women found them to be somewhat to
very distressing. “(W)omen with hot flashes experienced poorer sleep quality, higher
levels of fatigue, and poorer physical health compared to women without hot flashes”
(Stein et al., 2000, p.443). This same study also found a significant relationship between
hot flashes and poorer quality of life. As an exclusive symptom of chemotherapy, hot
flashes are unique in that they can provide reasonable evidence as to the potential impact
that this treatment alone can have on women.
The Janz et al. (2005) study found evidence to suggest “that adjuvant
chemotherapy had a greater impact on QOL than which surgical procedure was
performed. While the largest QOL differences were found in areas of body image and
future perspective, meaningful differences were also observed in social well-being and
fatigue” (Janz et al., 2005, p.1477). Also interesting to note, this same study found that
these QOL impacts had more of a detrimental effect of younger versus older women. It
can be speculated that this could, in part, be due to the side effects producing more of a
disturbance in the lives of younger women who may be working more, caring for a young
family, and possibly never having dealt with any prior major health issues. Janz et al
noted in this study that there did not appear to be any discrepancies across race when
testing for QOL changes, but did note that “chemotherapy had a disproportionately
greater impact on women with lower levels of education…(i)n this study women who
reported having less than a high school diploma were also more likely to be minority, of
lower income, and unemployed” (Janz et al., 2005, p.1477). This finding can have
implications on the types of support networks these women have and, similar to the
results found for young women, have more of a profound impact on their day-to-day
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functioning. Daily functioning includes not only being financially secure enough to miss
work, but also the toll that fatigue and all the other symptoms can take on women who
may have to do more active and hands-on jobs. Carver, Smith, Petronis, and Antoni
(2006) had slightly different findings in their study on QOL. They found that “Hispanic
women reported more frequent negative feelings, more social avoidance, more distress
about their family’s future, and more distress about the possibility of recurrence than did
other women” (Carver et al., 2006, p.756). Spencer, Lehman, Wynings, Arena, Carver,
Antoni, Derhagopian, Ironson, and Love (1999) said that “(a)lthough differences
emerged between age and ethnic groups in profiles of concerns felt and distress levels
experienced, associations among the variables did not vary significantly by subgroup”
(Spencer et al., 1999, p.167). Spencer et al. (1999) also found no correlation between
these differences and socioeconomic status and went on to infer that the reason Hispanic
women reported higher levels of distress may be due to cultural factors, such as
acknowledgement of feelings being appropriate for them culturally. In contrast, Spencer
et al. found that African American women reported much less concern regarding pain and
sexuality. Again, the researchers speculated as to whether or not this was due to culturally
maintaining a strong image.
As previously mentioned, several studies have found that in the long term,
chemotherapy does not result in significant declines in QOL. While Schou, Ekeberg,
Sandvik, Hjermstad, and Ruland (2005) found this to be the case in their study, which
looked at health-related QOL predictors, they also found that QOL did decline
immediately following cessation of treatment for some populations. “(P)oorer social
functioning was associated with chemotherapy at three months and younger age at three-
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and 12-months” (Schou et al., 2005, p.1820). Contrary to evidence from previously cited
studies, Schou et al. found no correlation between chemotherapy and cognitive
functioning. Winer, Lindley, Hardee, Sawyer, Brunatti, Borstelmann, and Peters (1999)
in their study state that “QOL was significantly better in patients who were disease-free at
the time of the interview compared to patients with evidence of recurring disease” (Winer
et al., 1999, pps.171-172). Said interview was conducted 12 months post-treatment for all
subjects. These results indicate with what relief people may once again to experience
their lives once their course of treatment has ceased, and with what dread those who have
to go through it again still feel. While the current study suggests that chemotherapy has
profound effects on women who undergo it, particularly with identity and QOL, the idea
that life can take on a new and positive meaning and level of enjoyment once treatment is
over is in line with this hypothesis. “An improvement in overall quality of life and
emotional well-being was demonstrated from before to 6 months after chemotherapy.
This is likely related to completion of chemotherapy treatment, resolution of
chemotherapy-related side effects, and return to normal living” (Hurria, Rosen, Hudis,
Zuckerman, Panageas, Lachs, Witmer, van Gorp, Fornier, D’Andrea, Moasser, Dang,
Van Poznak, Hurria, and Holland, 2006, p.929). Having once experienced such a
profound regiment of treatment it isn’t unusual to see many people seek to find
enjoyment in life, even if it is under a globally new way of thinking.
Finally, Zebrack, Yi, Petersen, and Ganz (2007) looked at how several different
factors prior to treatment affected long-term QOL. In regard to age, they found that
“older individuals may not be faced with concurrent demands of work and childrearing,
which may complicate adaptation in younger individuals and lead to more distress and
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poorer QOL” (Zebrack et al., 2007, unknown page #). Other demographic factors also
influenced QOL, including income level and comorbidities (Zebrack et al.).
Sex
Sexual functioning and enjoyment is an area of QOL that bears consideration as it
is also affected by chemotherapy. Winer et al. (1999) found that a “large proportion of
patients reported decreased sexual interest and activity, as well as pain or difficulty with
intercourse, at the time of the interview” (Winer et al., 1999, p.172). They also
acknowledge that “(f)urther research is needed to determine if changes in sexual function
are related to hormonal changes that occur as a consequence of high dose chemotherapy,
are representative of physiological sequelae of serious illness, or are due to some other
combination of factors” (Winer et al., 1999, p.172). In a 2006 study by Archibald,
Lemieux, Byers, Tamlyn, and Worth, the researchers looked specifically at the symptoms
of chemically-induced menopause (prompted by chemotherapy) and women’s sexual
functioning. “During interviews, 21 participants (70%) described experiencing one or
more negative changes in their sexual functioning associated with CIM (chemicallyinduced menopause)” (Archibald et al., 2006). This decrease in sexual functioning “was a
negative and meaningful experience for the majority of the breast cancer survivors in this
study. For many of the women, negative changes in sexual functioning introduced a sense
of guilt, frustration or anger, or led to worries about their future well-being or their
relationship with their partner. Often changes in sexual functioning were closely tied to
how breast cancer survivors viewed themselves as women or sexual beings” (Archibald
et al., 2006, p.100). Sexual functioning and identity are considered to be integral parts of
QOL for most people. The impact of chemotherapy on this realm of identity for many
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women is profound and can lead to new and different thinking about sexual identity,
functioning, and desire for a long time following the end of active treatment. Taylor,
Lamdan, Siegel, Shelby, Hrywna, and Moran-Klimi (2002) did a more specific study and
looked at how breast cancer and its treatments affected African American women and
their sense of sexual attractiveness. They “conceptualized sexual attractiveness as a
construct that is related to body image and thus expected to find results similar to earlier
studies of body image that were conducted with largely Caucasian samples” (Taylor et
al., 2002, p.513). The results that they found were that “addressing concerns about body
image and sexual attractiveness received low priority” (Taylor et al., 2002, p.514) for
African American women when discussed in a group therapy setting. This could be due
to either the nature of the issue, the nature of the setting in which it was being discussed,
or some combination of the two, for the women. Regardless, the researchers “found that
it was the women who had chemotherapy in combination with a lumpectomy who
reported the greatest difficulties regarding feelings of sexual attractiveness” (Taylor et al.,
2002, p.513). They attributed this, in part, to the side effects of chemotherapy, including
loss of hair, discoloration of the skin, and weight gain. Whatever the severity, area, or
personal impact chemotherapy has on sexual functioning and attractiveness, it is a factor
in identity and this makes it worth further consideration.
Treatment Decisions
The potential for being affected by chemotherapy doesn’t just begin when a
woman is diagnosed with breast cancer. Rather, its implications and side effects are in
mind for many women during cancer screenings, such as mammograms. One study found
that women with locally advanced breast cancer had delayed screening due in part to the
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fear of side effects of treatment (Mohamed, Williams, Tamburrino, Wryobeck, and
Carter, 2005). These women “denied having yearly mammograms or performing monthly
breast self-exams” (Mohamed et al., 2005, p.403). Within this same study, these women,
when compared with the control group, showed no difference between education,
employment, marital status, or awareness of preventative health guidelines. Additionally,
both groups reported the same percentages of those with health insurance. A possible
conclusion from this could be that there is a segment of women in the population who
wind up with locally advanced breast cancer that is due in part to their fear of
chemotherapy and its side effects.
In a very different study from the previous one, Muir, Meiser, Tucker, Andrews,
Tucker, K., and Friedlander (2004) looked at women in a high-risk group for breast
cancer and their willingness to participate in chemoprevention. Chemoprevention is used
as a means of reducing the risk of breast cancer in high-risk women by using drugs such
as tamoxifen, an estrogen suppressor (Muir et al., 2004). The study found that around half
of the women interviewed would be willing to participate in clinical trials of
chemoprevention with the other half citing that they would not be willing to participate
for “fear of side effects” (Muir et al., 2004, p.43). While participating in such a measure
to maybe prevent the possible development of breast cancer may seem extreme, some
women may view it as a way to avoid later, and possibly worse, side effects from actual
chemotherapy. For these women it is a price they are willing to pay, which is a factor that
cannot be ignored.
The end of treatment is a time during which women can experience very
ambivalent feelings about chemotherapy. Despite its numerous side effects, many women
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perceive some courses of chemotherapy with high rates of side effects, such as
adriamycin, as being more effective and aggressive than other courses of chemotherapy
with fewer side effects (Irwin et al., 1999). With this in mind, it should come as no
surprise that for many women the end of chemotherapy, and cancer treatment as a whole,
represents a time of crisis and worry (Arnold, 1999). Fear of recurrence may emerge as a
large concern for many women, particularly those who acknowledge that while they were
in chemotherapy they felt like they were actively fighting their cancer. A subject in the
study by Arnold (1999) said “I guess having medical people taking charge of your life
and body makes me feel more secure and being on treatment made me feel that at least I
had something in my body fighting to kill the cancer….To be honest, it scares the hell out
of me sometimes not having that ‘safety net’ of treatment” (Arnold, 1999, p.27). As
Arnold states in her summation of this statement: “(t)reatment may be an anxietyprovoking unpleasant experience, but it is a proactive process that gives many women the
comfort that they are ‘doing something’ instead of waiting to see what the future holds”
(Arnold, 1999, p.27). The expectations of others also weigh heavily during this time, as
one subject reported, “(p)eople on the outside assume that once you are ‘cured’ and ready
to return to whatever you did before with the full vim and vigor of the ‘before’ cancer
you- as if nothing happened” (Arnold, 1999, p.29). What “happened” for these women
was that they underwent intensive chemotherapy and many of them will be dealing with
the after effects and consequences of this for an undetermined amount of time. They
grapple with both the fear of the unknown future, and integrating their treatment
experiences into what they know about themselves and the world. “Before my last
chemo, I loved being alone in the house when my husband and daughter were out of
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town, but now I hate being alone and fear choking to death while eating alone, or getting
very ill in the middle of the night when I’m alone” (Arnold, 1999, p.32). Fear of the
future, both recurrence and the unknown, is a valid fear for many of these women.
Supporting these findings, Chantler, Podbilewicz-Schuller, and Mortimer (2005) found
that “participants in our focus groups reported exaggerated fear of cancer recurrence and
death from breast cancer. Fear began with the diagnosis, abated while on active therapy,
and worsened as active treatment was completed and contact with health professional(s)
decreased” (Chantler et al., 2005, p.75). There is a balance needed between
understanding the benefits of chemotherapy and truly being in touch with its potentially
life-altering consequences.
Partners/Caretakers
The role of caretakers and partners is an important one during chemotherapy.
They spend the most time with the women and often witness many of the chemotherapy’s
side effects firsthand. A study by Segrin, Badger, Dorros, Meek, and Lopez (2007) found
“emotional contagion on anxiety, emanating from partners to the women with breast
cancer, but not vice versa” (Segrin et al., 2007, pps.639-640). This indicates yet another
realm in which women may have to face symptoms from their chemotherapy: the distress
that it is causing their partner to watch them undergo treatment. Additionally, this study
found that women’s anxiety and depression were closely associated with their partner’s
levels in these realms. “(P)artners’ anxiety was positively associated with depression,
symptom distress, mental fatigue, and physical fatigue, and negatively associated with
symptom management among women with breast cancer” (Segrin at al., 2007, p.640).
Thus, it would seem that a partner’s management of his/her anxiety and depression is
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critical to the woman’s ability to cope with her own psychological side effects.
Similarities in feelings experienced by partners to women also was found in the study by
Mohamed et al. (2005). This was a study that examined treatment decisions made by
women with locally advanced breast cancer. They found “significantly greater depression
and active religious surrender than the control partners” (Mohamed et al., 2005, p.403)
which correlated with the “(g)reater active religious surrender” (Mohamed et al., 2005,
p.403) seen in the women with locally advanced breast cancer. In the study by Chantler et
al. (2005), the authors found that women with male partners tended to report that the
“men were less ‘emotionally available’ than women” (Chantler et al., 2005, p.76).
Overall, “(m)en were effective in providing verbal statements of encouragement and
optimism. Although this support was viewed as being extremely helpful at the point of
diagnosis, women became frustrated when they requested support by discussing less
optimistic aspects of their disease” (Chantler et al., 2005, p.76). It may be that when a
husband is vicariously experiencing the effects of his wife’s chemotherapy he is less
likely to be able to provide the kind of psychological support that she may feel she needs.
Harrison, Maguire, and Pitceathly (1995) found that it can be especially difficult for men
watching their wives undergo treatment as she is usually the person to whom they are
closest emotionally, thus making it harder for them to burden her with their own feelings.
This could be true for all caretakers in that they may find it difficult to manage their own
emotional reactions to seeing their loved one go through chemotherapy and subsequently
have a hard time providing the kind of support the woman needs. There are many ways in
which this could affect the woman, but this has yet to be studied. It has been shown that
it’s common for couples to draw on their mutual bond “to develop their confidence in
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their ability to deal with the issues associated with the disease (dealing with the unknown,
the threat of loss, the uncertainties and changes, and organization of the support network)
and to transform this experience of suffering into a meaningful and constructive life
experience personally and conjugally” (Picard, Dumont, Gagnon, & Lessard, 2005,
p.132). However, this same study also confirmed that in order for these more positive
outcomes to happen, it was important that “love existed before the disease” (Picard et al.,
2005, p.132). Ideally this would be the case in all relationships but sadly, is not. Many
women undergo chemotherapy and other treatments without the emotional,
psychological, mental, and physical support of a loving partner. “(F)eelings of fighting
the battle of cancer alone may be frightening and contribute to a diminished sense of
well-being” (Arnold, 1999, p.31). Sense of self and worldview may be just two schemas
that could be affected by such an experience.
The end of treatment marks another time of transition for women and their
support networks. In Arnold’s study one respondent remarked that “(o)nce treatment is
over, you have no one to talk to” (Arnold, 1999, p.30). This feeling may result, at least in
part, from the woman’s own internal struggle to incorporate new thoughts and beliefs into
her existing schemas. She may feel alien in the world in which she previously operated.
Conclusion
There is still a lot to be learned about the effects of chemotherapy and how they
affect survivors. Once faced with a treatment regimen that many consider to be worse
than the disease, it doesn't seem unexpected that many people experience a shift in some
of their previously held beliefs and views. Sense of self, worldview, sexuality, and
religion are a few examples of realms that may be influenced. As the literature has
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shown, chemotherapy has many side effects, not all of them physical. This study seeks to
find out more about the consequences, expected and unexpected, positive and negative,
that women experience as a result of their having been through this arduous treatment.
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CHAPTER III
METHODOLOGY
This study is an exploratory look into the types of quality of life changes women
may experience after receiving chemotherapy for the treatment of breast cancer. It is
based on the premise that facing such a serious and potentially dangerous treatment may
have profound and lasting effects on sense of self, spirituality, relationships, and
worldview. The study was designed using content analysis to code for themes that
emerge across participants. Through an hour long, one-on-one interview, participants
were asked to reflect back on the nature of their chemotherapy experience. The interview
questions centered on the physical, emotional, mental, and spiritual areas of identity. The
open-ended structure of the questions was designed to prompt further exploration of the
topics through narration, and as such, were specific to this study. “Available instruments
are not generally used because this would defeat the basic purpose of the research: to
learn inductively about a phenomenon that was previously unknown or poorly
understood” (Anastas, 1999, p.354). The goal was to invite participants to evaluate the
ways in which they perceived themselves to be different than they were prior to breast
cancer, and process what changes, if any, were due to the chemotherapy experience. The
questions were developed and set through intuition and collaboration with the thesis
advisor and were designed to allow subjects to evaluate if they felt an area of identity had
been affected. Questions were not based on the literature as such, as this is a preliminary
and exploratory look at whether or not areas of identity were affected. Questions were
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open-ended with the intention of inviting subjects to explore the topic further. The
questions were not asked according to category, rather a brief summary of the course of
treatment was requested and subjects were then asked to give narrative responses around
areas of identity, concerns, and side effects. At times, clarifying follow-up questions were
asked based on answers given, but the script was strongly adhered to.
The interview guide (see Appendix D) was based on flexible method research and
was intended to garner as much information as possible, which included direct
observations and context.
The researcher, the people and phenomena studied, and the inferences made about
them are seen as part of an open, interactive, potentially fluid situation. The
credibility of the findings of flexible method studies often flows directly from this
inclusion of context, of everyday social and psychological complexities, in the
picture. (Anastas, p.61).
Themes, concepts, and words from the answers provided were later identified and coded
and used for content analysis. The sample was obtained using a volunteer, snowball
method in which participants often referred other eligible survivors into the study.
Sample
There were 11 participants in this study. All were women who had undergone
chemotherapy for the treatment of breast cancer. These women were required to be
between six months and five years past the end of chemotherapy and 18 years of age or
older. Recruitment took place via the nonprobability method of snowballing.
This technique is used either with convenience or purposive samples when there
is initial access only to a very limited number of identifiable sample members.
These few people who meet the sampling criteria are recruited, and they in turn
are requested to identify other people like themselves who would be eligible to
participate in the study. (Anastas, p.289).
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The exploratory nature of the study allowed for this method of recruitment as a basis for
beginning to gather initial data. There were no additional age or race requirements,
however, the participants were all female, which lent some homogeneity to the sample.
Selection procedures were only random in that all participants who were contacted
through the network, met the requirements, and agreed to participate, were included.
There was no selection bias based on initial conversations with the researcher as to the
nature of the participant’s chemotherapy experience, thus allowing for any possible
“negative cases” (Anastas, p.61). At the end of each interview, each participant was
asked if she was aware of any others who would be willing to be interviewed and was
welcomed to provide the researcher’s contact information to them. Initial subjects were
recruited through friends of acquaintances known to the researcher. This allowed for at
least two degrees of separation between each participant and the researcher. Demographic
information including age, date of diagnosis and stage of cancer, family history of cancer,
race/ethnicity, occupation, marital status, and religious affiliation were gathered in order
to consider data in terms of support networks, lifestyle, and beliefs and to compare the
data both within the group and to the larger population (see Appendix C). This
information was gathered via a brief questionnaire that participants filled out immediately
preceding the interview and after signing the Informed Consent. In the case of phone
interviews it was mailed out to participants prior to scheduling the interview, along with a
stamped and addressed return envelope. Interviews were set-up upon return receipt of
both the Demographic Information Data and Informed Consent forms.
Four of the interviews were conducted over the phone and seven were done in
person. All participants were Caucasian and the age range was 34 to 69 years old with the
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average age being 55. Eight participants were from Colorado, one from New York, one
from Georgia, and one from Utah. Date from diagnosis ranged from 10 months to 5
years, with an average of a little over 2 years.
Risks and benefits were discussed with each interviewee prior to the start of the
recording process. They were verbally informed that the primary risk of participating in
the study was that they may experience some degree of emotional stress or trigger and
that discussing an experience like chemotherapy can be upsetting and make them feel
vulnerable. They were reassured that they could stop the interview at any time.
Additionally, the women were provided with a list of mental health professionals, clinics,
and hotlines that were local to them in the event that they felt the need to talk to someone
following the interview. This information was researched and gathered by the researcher
prior to each interview and was on hand in case it was needed. Participants were also
reassured that all information gathered would be held in confidence by myself and that
my thesis advisor would only have access to it once all identifying information had been
removed. It was explained that their names would not be used in the study, they would be
randomly assigned a number, and identifying characteristics, such as age, would be
minimal.
A primary benefit of participating in this study was explained as being the
participant’s knowledge that her experience and sharing of it could potentially lead to a
better understanding and system of care for others who have to undergo similarly
invasive and traumatizing protocols. It was also explained that the chance to process the
experience and share it with another may provide new understanding about it for the
participant and may help her to think of it in previously unconsidered terms.
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Data Collection
Data was collected through a one hour interview with each participant (see
Appendix D). Each subject received, reviewed, and signed a copy of the Informed
Consent (see Appendix B) form prior to the start of the interview and was given a copy to
retain for their records. A Smith College Human Subjects Review (HSR) committee
approved the study and all of its materials prior to the first interview (see Appendix A).
Included in the Informed Consent was information about the nature and approval of the
HSR, contact information for both the researcher and the HSR committee, and
information about protecting confidentiality in line with federal guidelines. Additionally,
information was provided about local resources for participants to contact if they
experienced any harmful side effects triggered from the interview.
Quality of life variables including relationships, religion/spirituality, sense of self,
and worldview were addressed in the open-ended interview. Questions around topics
such as concerns about chemotherapy before, during, and after treatment, side effects and
their emotional effects, and any changes noticed emotionally, mentally, or physically
were included. Face-to-face interviews were conducted in the homes of the participants,
and over-the-phone interviews were conducted from the home of the researcher.
Interviews were audio-recorded using a small taping device and later transcribed by the
researcher. In the case of phone interviews, the interviewee was put on speaker phone and
recorded using the same device as used with in-person interviews. Each sample was
blinded by the assignment of a random number to the interview and the removal of all
identifying information, including names, from the interview transcriptions. The
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randomly assigned number was given by the researcher, and all information was coded
according to the number assigned to each interview.
Data Analysis
Data content was analyzed for themes with coding based on these themes and
then contrasted and compared with all of the information as a whole. Themes such as
emotions, worldview, change in spirituality, and type of symptoms were color-coded and
charted. As the study progressed and new or unexpected information was gathered, it
helped to inform other areas to explore with new participants. The complete transcription
of each interview allowed for the re-reading of the interviews, and further examination
and comparison of the data. Potential researcher-bias due to previous experiences with
chemotherapy was addressed through the non-leading and open-ended nature of the
questions.
Themes were assigned different colors for analysis and were highlighted
accordingly as they emerged in each interview. The themes included emotional
effects/coping/support, other effects/changes, side effects, sense of self, relationships,
spirituality, worldview, concerns, and causes of the changes. A master list was kept of the
color assigned to each theme, and each interview was reviewed and coded according to
these themes and colors by underlining the responses. Each theme was reviewed and
responses and quotes were recorded on a separate sheet of paper with similarities and
differences noted in patterns and responses.
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CHAPTER IV
FINDINGS
This chapter contains the findings from interviews conducted with 11 female
breast cancer survivors who have undergone chemotherapy. The structure of the
interview was designed to elicit narrative responses that reflected on the changes, if any,
the participants felt they had undergone as a result of receiving chemotherapy. Areas of
change included emotions that were affected, physical changes, relationships, worldview,
sense of self, and spirituality. To gain additional information around these topics,
participants were asked to reflect back on their chemotherapy experience and to discuss
topics such as side effects, support networks, and concerns. At the end of the structured
interview, participants were asked if there was additional information they wished to
share about the nature of their experience with chemotherapy.
The data from these interviews are presented in the following order: demographic
information of participants, side effects, emotional/coping/support networks, physical and
mental changes, sense of self, relationships, spirituality, worldview, concerns, and causes.
Participant Demographics
The sample size for this study was 11, all female. All participants (n=11)
identified as Caucasian. Christian (n=7), Jewish (n=2), and not affiliated (n=2) were
selected as religious/spiritual affiliation. The women identified as married (n=7),
divorced (n=1), single (n=2), and widowed (n=1). Most of the participants (n=9) reported
that they are still working, while the others (n=2) are retired. Several of the women (n=5)
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reported no family history of cancer, a few (n=3) reported a family history that included
breast cancer, and some (n=3) reported a family history of cancer that did not include
breast cancer. One participant, (n=1) did not report the stage of cancer with which she
had been diagnosed, a couple (n=2) were diagnosed stage 1, the majority (n=6) were
diagnosed with stage 2, and a couple (n=2) were diagnosed with stage 3 breast cancer.
Participants were between 6 months and 5 years from completion of chemotherapy.
Side Effects
Participants described a myriad of side effects that they attributed to the
chemotherapy. All participants (n=11) reported losing their hair, which was the only side
effect that all 11 had in common. There were varying emotional responses to this loss,
but all agreed for the most part that, as one participant put it, “it turned out to be a much
messier process than I would have anticipated. It comes out in clumps. It’s worse than
having a shedding pet.” Most subjects (n=9) described overwhelming fatigue, which one
woman described as:
Profound fatigue where you literally feel like, if you’ve ever had weights from
working out, like ankle-weights that you carry, felt literally, it was so hard just to
put one foot in front of the other. It just washes over you. Like, 3 or 4 o’clock in
the afternoon it’s like you run into a brick wall. You are so dead. You are gone.
Another subject described the fatigue as:
Your get up and go definitely got up and went. There isn’t anything that isn’t
sapping of your strength. And there were really days where I felt like I couldn’t
crawl out of the bed. I mean, you do, because you think ‘if I don’t get out I won’t
be able to.’
Other participants (n=3) reported insomnia. Most of the subjects (n=8) struggled with
nausea, but only a few (n=3) actually vomited. One woman stated that her nausea was so
“horrific…I had, basically from the day I got my first chemo until three weeks (after the
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last), just constant nausea and puking.” As a result, a few (n=5) described some weight
loss and (n=6) stated that their sense of taste was negatively altered. One participant
stated that “anything sweet was really disgusting tasting, it tasted just like I was
crunching on a sugar bowl.” Another stated “the food was terrible!” while a different
subject simply declared that “things didn’t taste the way they normally do.” Mouth sores
were reported by several women (n=4), which one described as “trench mouth” as well as
dry mouth (n=2). One woman stated:
As far as I can tell you, I forced myself to eat, I drank this rinse called ‘Magic
Rinse’ to deaden my mouth and throat so the sores would not prevent me from
eating. I continued to eat whether I liked it or not.
For one participant, she recalled her mouth sores as a sort of fluke:
My first infusion, they did not tell me to suck on ice cubes, so I lost the skin on
the inside of my mouth and I had pustules all over my face. I was miserable, just
miserable. My second infusion, the nurse came and hugged me and was almost in
tears and she said ‘I forgot to tell you to chew on ice. But the day I had you as my
patient my 93-year old mother slipped and fell, I was late for work. Please forgive
me.’ So I chewed ice during the orange infusion and I chewed on ice during that
whole infusion and I never got sores in my mouth again.
Four respondents reported having significant issues with neuropathy, which
included pain and tingling in their feet, arms, and hands.
And as a matter of fact, the doctors were like ‘If you start feeling tingling in your
fingers you need to take a week off’ because it can cause permanent nerve
damage. And my fingers started tingling but I was like ‘I don’t want to take a
week off, I want to be done.’ So now my fingers tingle. But whatever. If I had
taken a week off I don’t know if I would have gone back.
Another more common side effect experienced by several women (n=4) was
described as “chemo brain” or memory and cognitive impairment. All four also stated
that the effects had lasted to some degree post-chemotherapy. One woman said “I had
what I would call ‘chemo brain’ it made my mind foggy, so it was hard to keep my train
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of thought or my focus.” Another woman summed it up by saying “I would have a
thought come into my head and it would just exit.” Another frequent side effect was
varying forms of pain (n=5). This included joint and bone aches, headaches, and
generalized pain, which, for some, continued past the end of treatment. “I have a lot of
pain that I don’t tell anybody about, but I’m kind of sick of it.” Another described the
actual pain of the infusion:
I didn’t have a port because the drugs I was given were brand new and they were
not toxic to the skin. So I didn’t have to have the port. So it was just like touching
a hot oven. You knew, they’re putting in the saline, they’re putting in the other
bags of drugs, and as soon as the chemo hit you knew it because my arm was
literally on fire. Like you literally, you were fighting back the pain. So that was
the sensation during. And you were always cold, very cold. You could feel it was
ice cold and burning at the same time. So it was very contradictory in terms of the
senses.
Depression and sadness were another side effect listed by several (n=3) women
which one attributed to her “listlessness” of not being able to engage fully in her life.
Dizziness was described by a few (n=3) and one stated that she still struggled when
rolling over in bed. One woman developed a sore on the bottom of her foot that her
surgeon “scooped out” while another developed pustules on her face. Another woman
described her skin peeling so badly that she was afraid “if it keeps going my bone’s going
to show through.” Two women reported the loss of all of their nails while another one
simply stated that they had become extremely brittle. Dry eyes, runny nose, skin color
change, and diarrhea were each described by one woman as minor inconveniences.
Some less common side effects included one woman’s hallucination-like visuals
of orange and purple spots in front of her face, slurred speech, and listing gait while
walking, none of which she felt her doctor was able to explain to her. Sexual side effects
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were reported by two women, with one of them stating that “the drugs dry you up,
everything. So that has been really, really annoying. That was a side effect I never knew
about. It affects your sexuality.”
Side effects led to more serious problems for two of the women. While one
woman reported that she was initially thought to have a blood clot that turned out to be
nothing, another actually did get one, due to her port:
It was in my arm, my hand turned purple, you know, big swollen, like an elephant
arm. I was at work at it was pretty scary. They thought it was arterial at first. Then
they said ‘ICU’ and I thought ‘this is bad and that could kill me.’ I was more
scared with that than I was actually with the chemo. So it was a result of the
chemo, but it was more tangible for me to see that this was a potentially deadly
problem.
This same subject went on to say that:
I made it through chemo and then I developed a gall bladder problem and had to
have my gall bladder out, and I got an ulcer as a result of the chemo and
developed Gastritis.
One other subject experienced a rather serious side effect related to her already present
condition of Super Ventricle Tachycardia:
And that means every once in a while my heart starts beating very quickly, and if
I take a deep breath and sit down, it goes away. However, when you have chemo,
you get your Tachycardia, and you can’t get rid of it. So you end up in the
emergency room, where they stop and start your heart, you know, within a
second, in order to make it stop. I had to do that three times.
Emotional/Coping/Support Networks
Despite the disparity in marital status, all respondents (n=11) reported feeling that
they had an adequate emotional and physical support network. What this network looked
like for each of them, however, varied greatly. One woman stated that her husband was:
Just so wonderful and precious and kind and just helped me get through it so
much more, and I have wonderful friends from my church who decided on their
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own, when I started chemo, they came every Tuesday morning. So I was here at
home with our family, our daughters and granddaughters and grandsons.
Like most of the participants (n=9) this woman never drove herself to one of her
infusions, rather, she always had a ride from a friend, family member, or neighbor. In
contrast, two women drove themselves to every treatment and sat alone during them.
This was a journey I was making by myself. I’m a widow, I do have two sisters
and an 86-year old mother who doesn’t understand why I’m sick. And both my
sisters have spouses and children and grandchildren and they both work full time.
It wasn’t like they were there holding your hand.
The other woman who went through it alone stated that:
I thought this is like a new experience cause I’m learning all this different stuff. I
thought ‘I hate to be the guinea pig’ but someone’s gotta do it, you know? And I
felt that it was better that I got it than some young mother with children, like that.
I thought, cause I’m single, I’ve always been single. I’ve got brothers and sisters
and if something were to happen to me it would be no big deal. Well, it would be
a big deal, but you know, not like a family.
Despite going through each infusion on her own, each of these two women expressed that
they absolutely felt that they were emotionally supported by family members and friends
throughout the treatment. “My family members and friends were absolutely awesome,
including my neighbors. Everybody was very supportive. I never went to a chemo
appointment by myself.” All of the married women (n=7) stated that their husbands drove
them most of the time and sat with them, and friends drive them the other times.
My husband was distressed just generally over the whole situation, I don’t think
men deal with, particularly if it’s a female-oriented problem, and he was just
scared to death about what was going to happen and he was going to wake up
some morning and I wasn’t going to be there.
One woman made a cross country move halfway through her course of chemotherapy.
Her husband was her “100% caretaker” before the move, but due to work conflicts, she
found herself driving herself to treatments in their new home state. Despite the
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overwhelming amount of support that all women felt they received during treatment, one
said that:
I remember feeling really alone, even though I had tons of friends, and my
husband and my family were really supportive. I just felt like no one knew exactly
what I was going through.
Emotional effects experienced from the impact of undergoing chemotherapy were
expressed by most of the women (n=9) and two of the women described it as not being an
emotional time for them. One stated that “you really don’t know what you’re getting into,
so ignorance truly is bliss.” Another woman said both that “I can’t imagine not doing it”
and “well, you know, emotionally it’s terrifying. I mean, you, if you think about it too
much you’d be in a padded room.” Many women expressed the trauma of the experience,
with one stating “it is a traumatic time, no matter what you say or do, it’s traumatic.”
When asked specifically what the side effects had been like emotionally for her, one
respondent said:
Most of them were pretty scary, like when I had at least three different antinausea treatments, and it was the third treatment and none of them were working,
and I, plus I did lose my appetite. So I hadn’t eaten much, and I couldn’t even
tolerate drinking any water at that point, so that was pretty scary. I didn’t want to
have to go to the hospital because I was throwing up from chemo.
Two of the women found the loss of their hair to be among the most difficult side effects
for them emotionally. One woman said:
If anyone had ever said, you know, five years ago before I had breast cancer, that
it would be harder for me to lose my hair than it would be to lose my breast, I
would have told them ‘you’re absolutely crazy.’ I can honestly tell you that it was
harder for me to lose my hair than it was for me to lose my breast.
When asked why this was such a traumatic side effect, another woman put it this way:
You’re never really, in my opinion, emotionally prepared for that. Why your hair?
Because, in my mind set, it is the physical attribute that you’re sick. Nobody
knows by looking at you ‘oh, you’re sick.’ No hair? Cancer.
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When asked if she felt this was directly related to the chemotherapy she replied:
Exactly. Because if you have radiation that would not be the case, or if you had
cancer and didn’t have either one, that would not be the case. Correct. That is
absolutely correct. So it is the only outward physical attribute and it was literally
coming out in clumps. And I was horrified. That was the only time I cried.
Despite varying reasons as to why, and to what extent, the chemotherapy elicited an
emotional reaction, the majority (n=9) of the women solidly agreed that there had, in fact,
been emotional consequences related to the treatment.
Universally all (n=11) of the women agreed that they had made the correct
decision and did not regret undergoing chemotherapy. “I think I would be a nutcase (if I
hadn’t had it). I think I would be wondering every single day, did they get it all out? Is it
floating around in me?” One woman reported having had such inconsequential side
effects that she had questioned at one point whether or not she had ever really had cancer.
The others (n=10) however, definitely noticed they were affected. One woman who did
not report having any emotional changes or struggles stated that:
It was not exactly a party, but I had zero fear sitting there. I was not afraid of what
was going into my body. I have a friend who was afraid that all the drugs were
going to kill her. And if you want to look at it that way, you are taking poison,
and I would expect that you would be a freaking, nervous wreck. But I just
pictured it as my get-well juice. You have to if you’re going to take that junk…or
you would not be able to sit in that chair, it would be like a lethal injection.
All of the women (n=11) also agreed with each other in that they felt they had all chosen
the most aggressive form of treatment available and had done all that they could to ensure
that it would not return, despite concerns they may have had about the chemotherapy. “I
wanted automatically the best chance to live. You know, I have three kids at home.”
Another said “well, I really didn’t want to do it, but when he (the oncologist) told me that
was the treatment that he would suggest, I didn’t really think twice.” Another put it as

41

doing it “for me and my own emotional wellbeing, I had to do everything that was
possible.” One participant had a dramatic moment that had a profound impact on her, yet
she never wavered in her commitment to continuing:
The Adriamycin/Cytoxan, they call it the Red Devil because it’s actually red.
When the nurse came to inject it into my IV, she had to put on, basically,
chemical gear. Two pairs of gloves, the mask, and the extra gown. For me, my
husband and I went ‘this is not good.’ She has to put all this stuff on because it
can’t touch her, but she’s going to inject it into me.
One woman had a distinct moment of wanting to quit treatment, but agreed to continue
after discussing it with her husband:
It hit me that this was real and it’s not going away and it’s a long haul. And I
didn’t want to do it. And I told my husband I didn’t want to do it anymore, and we
kind of had a deal, cause I had always said ‘if I ever got cancer I would never do
chemo, that’s my outlook, that’s my fate, blah blah blah.’ So when I agreed that if
I was going to do it all, we kind of contracted in a way that I was doing it for him.
So, then, four weeks later I was like ‘there’s no way I’m doing this again. This is
ridiculous’ and so he said ‘let’s go back to the doctor and see if there’s more stuff
they can give you for the nausea, try it one more time and if it’s this bad or worse
we can decide what we’re going to do.
As for coping with the emotional side effects of going through chemotherapy, the
women reported a range of skills and resources. All of them (n=11) reported that while
actually receiving the infusion, they had no interest in being social with people in the
room outside of their support network. Many (n=8) reported that they slept through most
of the infusions as there was Benadryl added to their cocktails. One woman reported that
it was a nice time for her to catch up on her reading. “I came (alone) because I wanted to
read my book. I never have time to read, now’s a good time to read. I don’t need a bunch
of people around watching me get this, you know?” A few women (n=3) felt that it was
important and helpful for them to maintain an exercise regimen to help them cope.
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Lingering emotional side effects remain for most (n=9) of the women. These
range from the sentiment that they are “done” and will not ever do chemotherapy again,
to the “voice of paranoia” that most (n=7) of them described as being ever present in the
back of their heads. These women hope that someday they will not attribute every ache
and pain to a possible reoccurrence of cancer. Two of the women also described lingering
emotional effects upon seeing the chemotherapy room again during subsequent doctor’s
appointments. “Now when I go to my doctor’s and I catch a glimpse of that room, it
makes you feel funny. I think my husband, too.” The other woman stated that “I can
remember the smell of the chemo room and I can remember the smell of walking into the
hospital. I don’t remember going home.”
Finally, several women (n=4) talked about the difficulties and emotional impact
of not feeling like their doctors were forthcoming with information. One said that “what I
resented the most was my oncologist and my nurse not saying to me how hard it would
really be.” Another said, “I will tell you one thing, there’s not enough information given
to chemo patients, I don’t feel, by their doctors. The doctors are very bad about giving
you information.” Another expressed anger about this, saying:
I’m angry about that because I know I’m not alone in this. And they give you this
song and dance when you’re a deer in headlights. You really don’t know a darn
thing about what they’re talking about. I think that needs a great deal of revamping.
The fourth woman explained this lack of information from another angle, saying that:
I think that one of the things is that they don’t tell you a lot of the things that are
going to happen. And there’s a good reason for it. The doctor said ‘I’ll be honest
with you, if I told you what was going to happen, you wouldn’t do it.’ I think, it’s
a very viable point of view. It’s not pleasant. I would have done it, but I know
other people who wouldn’t.
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While all the women agreed that they had made the best possible decision for themselves
at the time, the emotional consequences and repercussions were different for each of
them.
Physical and Mental Effects
All of the participants (n=11) reported some kinds of physical consequences from
the chemotherapy. Most of the women (n=7) stated that while they felt slowed down by
the chemotherapy, they didn’t feel overwhelmingly terrible.
I pretty quickly realized I could work and maybe school, or maybe a little
exercise. It put limits on me and made me re-prioritize what activities I wanted to
get done everyday and that sort of thing. But I’ve definitely seen people way
worse off.
One participant said that she “wasn’t really fatigued until it was kind of all over. And I
was thinking, ‘I don’t know if I’m fatigued or just lazy now.’” Another said she felt she
“has less stamina now” and that “I feel like I’ve aged more than I would have if I had not
had (chemo).” One of the younger women said she had told her doctor “I think I was born
at 100 and now I’m 68 because I have a lot more in common with 68 year olds” due to
the physical consequences of the chemotherapy.
The remaining women (n=4) reported more severe and persistent physical effects
from the chemotherapy. These four women also reported much more difficulty with
treatment. One described it as:
Well, physically it was kind of like crawling out of a hole everyday. Um, you
know, once you got up on level ground it seemed a little bit better. But the idea of
lying in bed and you think ‘well, I have to get up and take a shower.’ It was
almost kind of more than I can bear thinking about. But once you’d gotten
yourself out of bed and you’d turn the water on and you get in there and think ‘ok,
this is gonna make me feel better.’ There’s a lot of talking to yourself and kind of
self-motivating. I’m not one too…I don’t do sick well.
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When asked about negative physical changes that had resulted from chemotherapy, one
woman declared, “you know, you get negatives, but they become very trivial compared to
going through chemo.”
Exercise was a primary coping strategy for dealing with the side effects for a few
(n=5) of the participants. One told a story about a local radio show talk host who had
been diagnosed with breast cancer shortly before she had been and how she had worked
out everyday and had still managed to do her daily radio show.
Before that I don’t think I realized that you could keep up a pretty decent level of
activity and then since then I’ve read that it can really help you tolerate the whole
experience better, if you can even just go for walks, or some physical activity.
She found this example to be very inspiring for her and it helped motivate her to keep up
with her own exercise program, which she credits with keeping her side effects from
being much worse. Another said that her perspective on exercise was “it could have been
worse, maybe I could have been a lot sicker.” She maintained a schedule of running
everyday that she was able and skiing as often as she could. A younger participant was an
aerobics instructor and said she simply reduced her teaching schedule to three classes a
week while undergoing treatment. She felt that this helped her cope physically and
emotionally, however, she also believed that she was still suffering from some of the
fatigue-like side effects:
Our lives are crazy busy normally, but I definitely feel like there’s a big rock on
my back. I still go 100 miles an hour, but I’m just like dead tired every night. So I
guess this is my new normal, but I can’t remember what my old normal was.
The women who maintained their exercise schedules (n=5) all agreed that this was a great
help to them. One of the non-exercising women admitted “I don’t exercise, I never have,
I never will. But I would have people come over and walk with me because walking is so
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good for you, and I hated that more than life.” In addition to exercise, nutrition was also
cited by several ladies (n=4) as being a way for them to cope with chemotherapy. One
said, “I forced myself to eat more nutritiously than anyone you’ve heard of in your entire
life. Spinach, collards, all kinds of really good things, everything I know to be
nutritiously good for the body.” These four women all agreed that food became a main
way for them to respond to the treatment. One put it this way:
I read everything on the Internet, got as much info as I could cause I think when
you have info you don’t worry as much about that type of thing. So I looked at
what chemo does to your body, about physical therapy, about food, diet
supplements, I just looked up everything. And then I felt ok about it.
Being mindful of eating healthfully and nutritiously was a way in which these four
women maintained a sense of control about what was happening to their bodies.
One of the most persistent side effects reported by several (n=5) participants was
a change in cognitive functioning, or “chemo brain.” While not all of the women
mentioned these effects, and several (n=3) specifically stated that they had not noticed
any cognitive changes, ‘chemo brain’ was a term recognized by all of the women (n=11).
One woman cited her continuing issues with memory, processing, and “lack of clearheadedness” as affecting her job and relationships with her co-workers. Another said, “I
definitely feel slower. I have to pay attention to what I’m doing or I get scatter-brained.”
One of the younger women said, “I always say, even now, I have chemo moments like
brain farts or early Alzheimer’s. I’ve noticed that I never used to have them.” Another
described how it affected her daily:
I really don’t feel that I’m back mentally 100%. My short-term memory is coming
back little by little but it’s not as sharp as it used to be. Sometimes I can’t get the
right vocabulary words out, I misused a lot of words right after. There are a lot of
words that just sort of slipped through my head and it really bothered me. I’d
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explain to people ‘I’ve got chemo brain and I’m not really thinking correctly.’ If I
forget an occasion I just send a card late and say ‘sorry, it didn’t register with my
chemo brain.’
The three women who reported no cognitive side effects all agreed with one another that
they had, at some point during treatment, feared that they might experience it.
For five of the women, hair loss was identified as one of the most troubling
physical side effects. One woman said that when she lost her hair two days prior to when
her doctor told her she would that it was the only time of her entire illness that she cried.
Another woman felt it was hard for her because, “for a woman it’s a hard thing when all
your hair comes out. Cause when you have a husband or a family, or a boyfriend, you
know, you just, it’s a hard thing.” Another woman described the loss of her hair being the
outward sign to the world that she was sick:
I could sort of maybe say ‘it’s not that bad, it’s not that bad.’ But when I lost my
hair I had to say to myself ‘this is bad, this is really bad. You’re sick and this is
life threatening.’ You know, all the things I already knew, but maybe that hair
loss made it all that much clearer.
Another put it this way:
Well, I guess, while I still had my hair no one knew so I could fake it. But once
your hair falls out you’re a totally different person cause everybody knows, they
wonder or they look at you differently.
When talking about deciding to shave her head, another participant said:
I went one day, shaved my head, and that was kind of liberating for me. And that
was just kind of getting over that hump of ‘you’re gonna lose your hair, you’re
kind of losing it, now it looks horrible’ and then you just shave it and it’s done.
While all (n=11) of the women lost their hair during chemotherapy, several (n=6) said
that it had re-grown in a different way that they didn’t like. One described it as “crazy
curly” while another said:
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I came back with chemo curl, I’m part of the 70% where your hair comes back
like, different. I hate it, I hate it short, I hate it curly. It came back bronze, black,
platinum, white. I’ve been blonde for almost 60 years, I didn’t know who I was in
the mirror.
One participant looked at the loss of her hair in a more positive light and said, “I got
upset when I knew I was gonna lose my hair. But my hair was so bad anyways, I thought
maybe I’ll get some new!” One of the younger women was upset not so much at the loss
of her hair, but at the hormonal changes that resulted from the chemotherapy and led to
“random hairs and adult acne.”
Two women specifically mentioned that they felt they had sexual side effects that
they had been unprepared for. One felt that her “sex drive is a lot lower” and the other
said:
Everything hurts, and that is just something that nobody tells you. And I have,
they just say that you atrophy in that area, and I believe it. The drugs dry you up,
everything. So that has been really, really annoying. That was a side effect I never
knew about. It affects your sexuality.
Both felt that this particular side effect was a direct result of the chemotherapy.
Finally, several (n=3) of the women felt that there was no reason for them to have
gotten breast cancer based on their healthy lifestyles. While two of them recognized that
their good health going into chemotherapy had probably made the treatments more
tolerable for them, all three were angry and confused at having to get it.
You know, statistically, I shouldn’t have had breast cancer. You know, I didn’t
smoke, I didn’t drink, I was not overweight, there was no history in my family. I
shouldn’t have had it. But I got it.
Another said:
I kinda went through the stages of grief, just like they tell you, you will, I was
shocked, anger, I mean, I couldn’t believe it was me cause I’ve run, like, ten
marathons before. I mean, I like cookies, but…cookies shouldn’t give you cancer.
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For these women, having to go through chemotherapy was particularly hard in that it
seriously affected their belief that they had been living lives that protected them from
such harsh realities.
Sense of Self
Sense of self was explained to the participants as including the way in which they
view themselves and their identity. The most significant response given by the
participants was that most of them (n=7) felt that priorities had become even more
important to them in their lives. One described this as feeling like “things closer to home
have become more important” and another said:
I did come out of this realizing, one thing I have done and I will continue to do, is
we don’t put things off. Like if we talk about doing something, going somewhere
or doing something, if we can afford it and can find the time to do it, we do it. We
don’t say ‘we’ll do it in two years.’ We don’t tend to do that anymore. Life has
become very precious.
Another put it as:
Your whole outlook on life changes. The little things in life become very
important, like seeing the flowers and the trees, the birds singing and all that.
Grandchildren smiling.
One of the younger participants felt like it had helped to see a new perspective on her
life:
I always really appreciated life and I always knew that tomorrow could be
different, I always had a respect for the fragileness of life, it did reinforce and
help me become clearer on what I want out of life. But it does make you struggle
with that a bit, too. It seems like ‘how do I prioritize all these really important
things and make sure that happens?’
One woman felt that her perspective on herself had changed in such a way that she felt
the importance of becoming a more giving person in order to lead a more meaningful life.
She said, “life is not all about me. It’s about what you give back and if I was to die
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tomorrow, would I have made a difference?” Several of the women (n=5) also described
part of the changes in their self-identities following chemotherapy included them actually
liking themselves better. One woman said:
I think I’m definitely a different person. You have empathy now. I was probably
one of those people who would stare at the lady who’s hair was falling out, and
now I when I see them I have not sympathy, but empathy. I’ve been there and
done that, and it’s not just the hair, it’s everything that goes with it. But I think I
am much more attuned to other people than I ever was. Maybe I’m just finally
growing up…but it definitely gave me perspective.
Another woman came right out and said, “I probably like myself better because a lot of
the things that are kind of superfluous that meant something before, it doesn’t matter. It’s
just another day.” A woman who had particularly bad side effects and had said that “if
you had asked me five years ago ‘would you have chemo?’ I would have said ‘oh no, that
stuff will really poison you’” went on to describe herself as being “tough as nails” in the
face of her treatment and side effects and attributes much of her progress to this positive
attitude about herself. Several (n=4) of the women specifically described themselves as
being “strong” during treatment and one said that as a result of that strength she realized
“it’s quite incredible what you can get through.”
Some of the participants (n=5) really felt like their sense of self and identity was
really shaken or different as a result of their chemotherapy experiences. One said, “I think
I was shaken for awhile” while another described her sense in a bit more detail:
It’s definitely been affected, but I think more, the lasting effects of the chemo I
would say are, it’s my frustrations with my memory and being frustrated that my
brain doesn’t work as efficiently as it used to. But, so that affects my sense of self.
I don’t think I’m as articulate as I was.
When asked who one woman considered herself to be in lieu of having undergone
chemotherapy, she responded by saying, “I don’t want it. I don’t want to be a part of it, I
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don’t want it to be a part of me. Leave me, go away.” Three of the women also described
distinctively negative consequences that they felt and attributed to the chemotherapy. One
said “we have cancer, we will always have cancer. There’s no guarantee that there’s no
cell in our bodies that still exists.” Another phrased it as, “people comment continuously,
you must be normal and you want to scream cause you’re like ‘I’m not normal!’ The new
me. And I’ve read about it, but you can’t tell anybody.” This same woman described
these feelings in relation to her hair growing back and people assuming that was a sign of
her recovery and completion with the effects of chemotherapy. Part of the fear related to
changes in self had to do with the concern related to the chemotherapy not having worked
100%. One of the younger women talked about how she and her husband had always
planned to adopt a child someday:
The other piece is that I don’t know if in good conscience now I should adopt,
because I don’t know what…and I found myself struggling with that. I certainly
wouldn’t want to adopt a child and then die.
In contrast, four of the interviewees felt that very little, if anything had changed
about their self-identities. When asked about possible changes, one said, “not at all. Not
even slightly. As a matter of fact, if anything, I realize I have more self-confidence
because I realize that I am not a breast.” Another attributed the lack of change to her
tremendous sense of self-worth, saying, “I have an, I must have a gigantic ego. It was
‘this is what is happening to me, I’m still who I am. It’s not happening to my spirit.’”
All of the women were very sure in their feelings of whether or not undergoing a
treatment as intense as chemotherapy had affected who they thought themselves to be.
Despite full agreement from all of them that they would not have changed their decision,
not all agreed that they had made it through unscathed.
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Relationships
Most of the participants (n=6) felt that they had relationships that had grown
stronger or deeper as a result of them having gone through treatment. One of them
expressed that her relationship with her mother was the most profoundly affected by her
experience. She said:
I said to someone once, ‘man, if I had to go through that again now with my mom
being how she is now, I might do it again!’ She comes to visit and she’s helpful
and pleasant. My relationship with her has definitely gotten closer.
Another felt that her relationship with her husband had grown much closer since her
chemotherapy, “my husband and I have always had a wonderful marriage and been close,
but we’re even closer now.” Others expressed the change in their relationships by
comparing them to the people they felt they were no longer close to:
I think that by and large it brought me closer to most people. There are a few
people, some people just cannot handle the illness thing. And the obvious
problems that you have from it, it’s more than they can…but no one close to me
was like that.
Another described it as:
I’ve probably embraced the relationships with the people who gave me positive
energy and kinda let go a little bit of the people who had negative energy. So, the
positive relationships have gotten stronger and the negative ones I’ve tried to get
rid of.
Another woman felt that the experience had brought her much closer to her kids and that
had improved their relationships significantly. One woman saw her experience as being a
positive one for her relationship with her husband due to the fact that he was scheduled to
deploy to Iraq and instead received a compassionate reassignment back home. She said:
It’s so funny, we kid with each other, I say ‘if I had to do it all over again I would
if it meant you didn’t have to go to Iraq’ and he says ‘I’d go to Iraq if it meant you
didn’t have to go through it.’
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Some of the women (n=3) felt that there had been no real significant changes in
any of their relationships. While one described this as being the case, she also felt at the
same time that “I don’t know if it deepened it, but it made me more aware of none of us
know how much time we have left, so make sure you connect.” In general, these three
women felt that their relationships had proceeded through their treatments without many
effects. One participant reported that this was mainly due to the fact that she had adopted
an attitude of her treatment being a “non-event” and that she would not allow it to affect
her loved ones.
Finally, three of the women agreed that they had negative consequences in some
of their relationships during and following treatment. One of these women was one who
felt she had grown closer to her kids, but at the same time felt it had strained the
relationship with her boyfriend. She said, “my boyfriend says I’ve changed. He says that
definitely I’ve changed since going through all that. I don’t know that it’s a positive thing
in his eyes.” She indicated that she had much more uncertainty in her relationship with
him than she had prior to treatment. She went on to describe a time when she had almost
been hospitalized for a serious side effect and:
I remember that night, particularly, my boyfriend was watching the news to see
what the weather was like the next day so he could play golf and I, that was
disturbing to me. I thought, ‘I don’t even know if I’m going to wake up tomorrow
and you’re worried about the weather so you can play golf.’
Another woman said that her fiancé had actually broken up with her before her treatment
began. She said, “he just left. He brought me home from the hospital and just left.” She
felt that this was due to his discomfort at seeing her go through chemotherapy and face all
the potential side effects. The third woman who felt that chemotherapy had negatively
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affected her relationships felt that her development of “chemo brain” had adversely
affected her performance in the workplace, and thus also her rapport with her colleagues.
She said, “I would say, it affected my relationships with a couple of people I work with in
a negative way.” She went on to explain how this had made her workplace a more
uncomfortable place for her to be.
For the most part, the women’s relationships were not harmed in any way, and
many were described as “deeper”, “stronger”, and “closer” as a result of the
chemotherapy experience.
Spirituality
The women in the study varied from Christian (n=7), Jewish (n=2), spiritual
(n=1), and atheist (n=1). All but one of the women (n=10) felt that religion played some
part in their chemotherapy experience in helping them to cope and process. Eight of the
women stated specifically that religion or spirituality were a great support for them and
helped them manage their treatments better than they would have otherwise. When
talking about whether or not her relationship with God had affected her during treatment,
she said:
I think it made all the difference, it really did. I so often thought ‘if there was
someone who couldn’t turn to God in a time like this, how could they possibly
come through it without a lot of emotional problems? I think I would have felt
lost, I would have been afraid, I think I would have had extreme fear.
Another woman just expressed it as, “in terms of recovery it helped me to know that there
was some greater being that your thoughts could turn to.” One participant talked
specifically about how her religious beliefs helped her during her infusions:
I got a (feeling) of totally being levitated by God. I have a very strong religious
background, so I had absolutely zero fear whatsoever going into the infusion, zero
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fear while I was there, and zero fear during the time frame. No fear. I just felt that
God was lifting me up. I sat in a chair, if I started to get nervous I just said a
prayer, ‘Jesus be with me, comfort me, let me feel your arms around me.’ And
that got me through.
Another woman simply stated that “I probably believe more now than ever that God has a
plan and regardless of what you do His plan is gonna follow through.” For these eight
women, religion and spirituality were seen as absolutely crucial in their journey through
chemotherapy.
Two of the women felt that their spirituality increased while undergoing
treatment, while just one of them saw this as being integral to her recovery. One said, “I
think it increased my recognition for the need for some kind of spirituality” while the
other started attending church regularly. She said:
I definitely felt a connection, more than I had, I just really identified and the
things that the pastor said and does continue to affect me more I think than they
used to. I think I needed that spirituality at the time, I think I still do, you know, to
understand it.
One woman expressed that she felt that it had made her more “thoughtful” about
religion and spirituality. She said, “I haven’t really decided how I’m going to take it and
where I’m going, I do find myself thinking about it much more than I did before.” The
woman who identified as atheist said, “I actually don’t believe in God, but I didn’t
believe in God 20 years ago, so it has nothing to do with this. I didn’t look for help
anywhere but right here.” All of the women used their spirituality, or lack thereof, as a
way of coping and processing their experiences. To each, it was a topic that bore at least
some thought.
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Worldview
Worldview was defined in the interview as having to do with one’s sense of safety
and place in the world, view of world events, and level of interest in happenings around
them. All but two (n=9) of the participants agreed that their worldviews had at least been
affected by their experience of undergoing chemotherapy, but there was a great
divergence in what ways it was affected. Four of the women felt that they had grown
more interested or sensitive to world events. One stated this simply as being “more
interested in what’s going on in the world, instead of less” and another put it as being “a
lot more sensitive to other people’s needs now.” The other two of these four women felt
that it had increased the level of their interest in finding a cure for cancer. One said:
I think I appreciate more then ever how much time and money the drug
companies have put into research. And I’m grateful there is such a vocal breast
cancer lobby, because I do think that has an effect on how much time and money
and research gets focused on breast cancer. I’ve always appreciated the research
and development aspect of the drug companies and universities, but that
appreciation definitely increased.
Of the remaining women (n=5) who felt their worldviews had been affected, one
felt that she now worried less about issues like politics than before, saying, “I might have
dwelled on it more before, and I do not dwell on it anymore.” One woman felt it had
given her a “sense of a loss of, I don’t know if safety is the word, but you get a sense of
your own vulnerability.” Another woman found herself questioning humanity and
peoples’ actions more than she had before. She said:
I think that you look at the way the world is and you really, I found myself
wondering why people were actually trying to kill one another when there are so
many things that can kill them. Why work so hard? It just doesn’t make much
sense to me.
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Another woman felt her worldview change in that she was more able to let things go than
she had been able to before. She felt that “at some point I had to say ‘gotta let go, gotta
let go’ and let these things take place.” Finally, of the five women who felt their
worldviews had been affected by chemotherapy, the last woman said that “the way my
worldview was when I was sick was about me” and when asked if it was different since
completing treatment, she responded, “oh God, yes. I’m back to me.” This last woman
did not feel like her change in worldview had a lasting effect and that she was able to
return to the way in which she had previously understood the world.
Two of the women felt that their worldviews had not changed at all as a result of
going through chemotherapy. One simply said it is “pretty much the same” and the other
felt that “it has helped me be even more empathic, and I always thought I was pretty
empathetic. I think it’s just reinforced that worldview.” For the majority, there was at
least a small shift in how they thought about the world in some ways. For the others, it
either reinforced or didn’t affect these views.
Concerns Before, During, and After Chemotherapy
Participants were asked about their concerns about chemotherapy in a three-part
question. Concerns they had before their first infusion, during their course of
chemotherapy, and since the completion of chemotherapy were discussed in the
interviews. The women expressed a range of responses for all three of these time periods.
Before
The most common (n=3) concern before the beginning of treatment was how
family and loved ones would respond to it. One participant said her concern was “how to
take care of my husband. I wasn’t worried about me, I told him I was going to be fine. I
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was so worried about my husband and family.” Another woman was worried about how
it was going to affect her children while the third identified worry about her children and
about what the effects of the chemotherapy would be on her body. This third woman,
plus a couple of more (n=3) were concerned with how the treatments would make them
feel. One was concerned that “I would be throwing up around the clock and that it would
probably kill me” and another focused on not wanting “to wind up in the hospital” due to
sickness. Uncertainty and not knowing about what was going to happen were identified
by two of the women as their greatest concern. One said, “I didn’t have any idea what it
was going to do to me, or how I was going to feel” and the other stated that it was “the
uncertainty of it.” This latter woman also expressed concern about having to delay the
onset of chemotherapy due to a cold she had gotten and felt anxiety at the thought of
having to delay treatment and remain in a state of not knowing.
One woman was very candid in her admission that her greatest concern before the
onset of treatment was “hair loss. I mean, I was certainly concerned about how I was
going to feel, but that wasn’t my biggest concern. I would have to say that it was hair
loss.” Another participant worried that the treatment “wasn’t gonna work” and the
remaining women (n=2) felt that they had no concerns before the onset of chemotherapy.
One of them said, “honestly, I didn’t have any concerns about the chemo, I just felt like it
was something I needed to do and I would just go with it.”
During
Concerns that arose during the course of chemotherapy also ranged among the
women. Two women were worried about the pain and sickness they were experiencing.
One of these women found it very difficult to manage her nausea during the treatment
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which caused anxiety for her. The other woman said that the pain of the infusion itself
was so intense that she described it as “a horrible burning sensation.” Two more of the
participants said that one of their biggest concerns during their infusions was that they
could keep going and continue the course of treatment. One put it as “keeping my head
above water, keep going, day-to-day” and the other woman said to herself “alright, suck
it up and go do it because you have to do it and it’s the right thing to do.” Another
woman said that, while she only had four infusions and none were particularly bad, she
was worried each time that the next one was going to be the one that had a negative effect
on her. She said, “I was worried that maybe the first one wasn’t bad, if that’s all there is
to it then no problem. Then I thought, well maybe the second one, maybe they’ll get
worse each time.” Another participant found herself most concerned about “what it might
be doing to my body, it might be damaging my heart, so I was careful.” Another woman
was primarily concerned with fatigue during her course of treatment, saying that it was
“the kind of fatigue I’ve never experienced.” For another woman, her biggest concern
was that the chemotherapy “wasn’t gonna work” and she would have to face the problem
again. One woman expressed great concern over her family, saying, “they were so
worried about me. I hated that.” However, two of the women said that they felt they had
no concerns during the course of their chemotherapies. One said:
I really, you’re so focused on, sometimes the moment, I didn’t really have that
many concerns, and I actually would tell people, through a lot of it, there was a lot
of peacefulness to it because you didn’t really think about all the trivial things you
normally think about. I was in the here and now, in a strange sort of way it was a
very peaceful sort of experience.
Overall, most of the women struggled with at least one concern during the course of their
treatments.
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After
Concerns following the end of treatment were on a much shorter range than those
preceding and during. The great majority (n=8) of the women expressed some fear since
the end of chemotherapy of a recurrence. One woman put it as “when’s it going to come
back” rather than ‘if.’ There was a general understanding amongst all of the women that
if their breast cancer returned, it would be metastasized and prove much more difficult to
treat than the original occurrence. When talking about whether the chemotherapy had
really worked, one who had already had a recurrence said, “I pray daily that it did. It’s the
kind of thing where you really don’t want to think that there’s a possibility.” Another
woman had already experienced a recurrence and felt that “my biggest concerns have
shifted, before I’m sure I worried about a recurrence. And now, it’s highly unlikely to
recur (just) as breast cancer. Just a recurrence. Anywhere.” One woman said that the
thought of recurrence “plays into everything,” particularly around doctor visits. Another
woman put her concern as:
That it didn’t work, that it will come back. I think it worked, it served its purpose
for the round that I’ve been through, but did it kill everything and is there any still
floating around that’s going to show up at some point?
For two of the women, recurrence was not their main concern. One was struggling
with how her hair was going to look as it grew back in, while the other woman was
struggling with the thought that ‘chemo brain’ might come on in a delayed fashion for her
and affect her job performance. Only one woman said that she had no future concerns.
She said simply, “I don’t have any. I’m done. I swear to God.”
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Causes
Towards the end of the interviews, the women were asked to reflect back on their
experiences and evaluate what they felt had caused most of the changes and effects that
they had discussed. Two of the women very clearly felt that the chemotherapy itself had
the most profound impact on them. One felt that “categorically” she could isolate the
chemotherapy as the cause of all of her struggles, mainly because it was the thing making
her sick. She said:
For me, it was a continuum, you don’t like pretty much everything being done to
you. In my case they all just kind of came together, but it was the ups and downs
that would give you back your life for awhile. And you might find that is what is
good about chemo, you’re not locked away for six months in despair and pain,
and whatever. That instead you are able to be back in the world and everything. I
really, the chemo part of it, I can isolate it easily, it was so isolatable.
Four of the women felt that the diagnosis of breast cancer was the cause of most
of their distress and the psychological and emotional impact. One felt that it was the
diagnosis “because it came completely out of left field.” For these women it was the
moment of being told they had a life threatening illness that had the most profound
impact. Their courses of treatment were secondary to this moment and its meaning.
Five of the women felt that it was a combination of both the diagnosis and the
chemotherapy that had the greatest impact on them. One said, “I don’t necessarily think
you can isolate them out. It just becomes so complicated.” Another said “I can’t say that
chemo itself was the reason why I look and think a little bit differently and why I tend to
be impatient with people who focus on minutiae. I do feel it’s a function of the entire
process.” For another woman, the diagnosis led to an emotional reaction, but the effects
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of the chemotherapy had so many physical side effects that she felt herself have a strong
emotional reaction to it as well, making it impossible to distinguish between the two.
Summary
This chapter has presented the findings from 11 interviews conducted with
women who completed a course of chemotherapy for the treatment of breast cancer.
There were many themes that emerged in several areas, while in others, many of the
women described very unique experiences. Universally, participants agreed that
chemotherapy was the correct course of treatment to undergo in their treating protocols.
Not one of the women stated that she wished she had not undergone it, although many
expressed great concern at its effectiveness. All agreed that they felt they would be either
terminally ill or dead if they had not undergone chemotherapy.
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CHAPTER V
DISCUSSION
The objective of this qualitative and exploratory study was to look at possible
links between the experience of undergoing chemotherapy for the treatment of breast
cancer and subsequent psychological, emotional, and physical changes. This study
attempted to draw a distinction between the experience of breast cancer as a whole and
the process of undergoing chemotherapy. These elements were explored through
interviews with breast cancer survivors who had undergone chemotherapy. This chapter
presents the findings in the following order: 1) key findings, 2) implications, 3)
limitations, and 4) conclusion.
Key Findings
In the findings regarding side effects, the vast majority of the women reported
side effects that were in accordance with the literature. These included fatigue (Servaes,
Verhagen, and Bleijenberg, 2002), nausea (Molassiotis, 2000), hair loss (Buick, Petrie,
Booth, Probert, Benjamin, and Harvey, 2000), sleep disturbance (Buick et al., 2000),
neuropathy, vomiting (Molassiotis, 2000), and cognitive changes (Stewart, Bielajew,
Collins, Parkinson, and Tomiak, 2006), among others. Side effects that were not
mentioned in the literature include a blood clot, visual spots, and exacerbation of Super
Ventricle Tachycardia. It cannot be said that these side effects were caused solely by the
chemotherapy and not influenced in some way by existing factors. However, all of these
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side effects had further implications regarding the emotional, physical, and psychological
well-being of all of the women.
The findings regarding emotional changes, coping, and support networks were
supported by the literature in that the women with strong support networks and active
coping skills felt that they handled the experience well emotionally (Pieterse, van
Dooren, Seynaeve, Bartels, Rijnsburger, de Koning, Klijn, van Elderen, Tibben, &
Duivenvoorden, 2007). What was not mentioned in any of the literature was the general
agreement among the women that they had gained something positive in their lives after
having gone through chemotherapy. For some (n=7) it was the recognition and greater
appreciation of their relationships, some (n=7) felt they had re-evaluated their life’s
priorities, and others (n=5) even felt that they liked themselves better. These findings
imply more than just negative or neutral changes that take place during the process of
undergoing chemotherapy.
The findings about physical and mental changes were also in accordance with the
literature (Stewart et al., 2006), with several women (n=5) experiencing ‘chemo brain’ as
a negative occurrence and most (n=9) stating that they had suffered from physical fatigue.
These effects were closely linked with emotional changes such as depression, depressive
symptoms like crying, and irritation for eight of the women. One woman reported going
on anti-depressants during her chemotherapy due to her difficulty in dealing with the
physical side effects and how that was causing her great emotional distress. Two of the
women felt that their inability to exercise at their previous levels due to fatigue caused
them great sadness and frustration.
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Sense of self was affected for all but four of the women (n=7) in at least a
minimal way. What was interesting to note was that seven of the women reported liking
themselves better, while three of these same women also reported negative consequences
to their self-image. For one this included difficulties that had subsequently arisen in her
romantic relationship due to her becoming more assertive. This created a dilemma for her
in determining her ongoing status with this partner, to whom she was not married.
Previous literature does address improvement in emotional well-being (Hurria, Rosen,
Hudis, Zuckerman, Panageas, Lachs, Witmer, van Gorp, Fornier, D’Andrea, Moasser,
Dang, Van Poznak, Hurria, and Holland, 2006), but does not address the issue of overall
positive life changes experienced by women who have undergone chemotherapy.
Relationships were affected for eight of the women, with three noting negative
changes. Many of these changes were linked by the women with changes in self and
emotion. Several of the women stated that going through a process as harrowing and
difficult as chemotherapy helped them to realize who their true friends were, the people
they felt would stay by them through thick and thin. For some, the identity of these
people was a surprise. All of the married women reported tremendous support from their
husbands, while two of the single women struggled in their relationships with their
boyfriends/fiancés. One of the women in particular, who felt her relationship with her
boyfriend had been negatively affected, felt that it was related to the fact that he was as
committed to her as a husband would have been. She remarked on the fact that he was
free to leave at any point, as one woman’s fiancé did, which led her to have many
ambivalent feelings about having him in her life and led to him being inconsistent in his
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support of her. The woman whose fiancé left her after bringing her home from surgery
simply remarked that, “it could have been worse. We could have been married.”
Spirituality remained fairly constant in most of the women, with only one
participant self-identifying as atheist. Two of the women felt it had increased their levels
of spirituality as it helped them to cope with the treatment. Women who maintained high
levels of spirituality throughout the process attributed much of their progress to God, in
accordance with the literature and felt they coped well (Tartaro, Roberts, Nosarti,
Crayford, Luecken, and David, 2005).
Two of the women felt that their worldview was unaffected by the process and
maintained their previous perspectives. For the other nine women, responses ranged from
worrying less to worrying more to changing for a time and then going back to previously
held beliefs post-treatment. This latter example indicates a shift in worldview used as a
means to cope and process and then a move away from these beliefs in an effort to
distance herself from her ‘sick’ identity. Interestingly, this was the one woman who
identified as having no spiritual or religious beliefs and described herself as having a
“tremendous ego,” perhaps thereby explaining her need to return to her more ‘normal’
state of being.
There were many concerns expressed through the three stages of before, during,
and after treatment. What is interesting to note is that none of the women at any time
expressed a fear or concern with death. Rather, main focuses were on how to keep going,
concerns with whether the treatment was doing what it ought to, and loved ones. While
recurrence was a main concern for many (n=8) of the women, it was discussed more in
terms of future treatment implications than in terms of possible fatality.
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The findings around causes for these changes and effects indicate that the
diagnosis of cancer and the treatment of chemotherapy are quite wrapped up in one
another. The experience was described as one woman as “being on a continuum” and
described the diagnosis as having so much meaning, partly because of its implication of
chemotherapy, that it was impossible to distinguish the two from each other. Five of the
women felt it was not possible to distinguish one from the other, two felt that the
chemotherapy was the cause of their changes, and four felt that the diagnosis alone had
the most impact on them.
Implications
The implications of these finding for the field of social work include several
different factors. The purpose of this study was to raise awareness between the possible
links between a life-threatening treatment for a life-threatening disease and possible
emotional and psychological side effects that should be addressed by the mental health
community. This study has shown that undergoing chemotherapy for the treatment of
breast cancer does, in fact, have at least a minimal effect on the emotional well-being of
survivors. Mental health professionals should be prepared to identify and discuss
chemotherapy-related issues independently of the greater cancer experience.
Another implication from this study is the tremendous positive response that
many of the participants reported having had. Further research on this angle of the
process would be interesting in assessing how life-threatening situations can profoundly
affect people in life re-evaluating ways. Consistency of responses and reactions from this
subset of women indicate that this is an area that may have far-reaching implications.
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Differences between married versus non-married women as related to support
networks and changes in self-identity is another area that bears the need for more
research as there are implications here about how relationship status can have profound
meaning and consequences. Is there a difference in level of support when there is a legal
commitment to another? This theory would be supported by the example of the woman
whose fiancé left her right before the beginning of treatment while none of the husbands
did the same. Is this commitment culturally reinforced, and if so, how? This also has
implications for how single women may have been treated differently by their medical
team than married women. What alternative support systems do single women have, and
to what extent do they feel they can reliably count on these networks?
Another common sentiment during the course of the interviews was women
feeling like their doctors had not provided them with enough information about their
course of treatment. Perhaps a need for more information about side effects, emotional
and psychological impacts, and resources for coping need to be more openly shared by
doctors with their patients. One woman suggested that having a person on her treating
team who’s sole purpose was to help her understand the medical jargon and the side
effects would have been extremely helpful. A study around how much information
provided to patients is helpful, and how much is too much, could be a very useful tool for
the cancer community. Admittedly, there is a fine line between knowing too little and too
much. One woman reported that she immediately found that she had to stop looking at
the Internet as it was overwhelming her with information. Still, a balance between helpful
knowledge around what is happening, and a certain amount of ignorance may prove to be
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key in helping women manage their symptoms and experiences and maintain a sense of
control.
Limitations
One of the main limitations of this study is that it was done on a subset of greatly
similar women. All identified as Caucasian, all but one as spiritual or religious, and all
with an adequate support network. It was also difficult to ascertain causes for effects and
changes experienced by the women by having them focus solely on their memories and
retrospectively. Possibly doing a study in which women are interviewed both before and
after chemotherapy could yield more conclusiveness in the distinction between the cancer
experience as a whole, and the chemotherapy effects.
Another limitation is that all of the women in relationships were with men. There
was no consideration in this study for same-sex couples and the implications of a partner
undergoing chemotherapy. All women in this sample were also self-selecting in their
decision to participate. Since they were recruited via word-of-mouth there is an implied
web of relatedness, both among themselves, and with the interviewer.
Conclusion
The current study provides useful data on changes that occur during and following
the use of chemotherapy to treat breast cancer. While many themes did emerge, each
woman’s narrative and story was uniquely her own. Each had a very private experience
of going through treatment and felt that she had gained something within herself or her
life that led her to want to participate in this study. No one experience, relayed during the
course of a single interview, can express the tremendous courage with which each of
these women, and all those who undergo the daunting rigors of such a treatment, faced
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their mortality. As one woman put it, and as each expressed in her own way, “it’s life
changing.”
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Appendix A
Human Subjects Review Application and Approval Letter
Investigator Name: Amy Willson
Project Title: The Breast Cancer Survivor’s Experience of Undergoing Chemotherapy
Project Purpose and Design
Chemotherapy is a concept that strikes a chord inside many people, conjuring
images of nausea, hair loss, and pain. It is synonymous with cancer. The impact of
undergoing treatment for a life-threatening diagnosis like cancer can have both seen and
unseen impacts on the person, their families, and their loved ones. The effects can
reverberate through a person’s life, affecting not only their health status, but also their
relationships, careers, sense of self, worldview, and spirituality. When chemotherapy is
chosen as a method of treatment this impacts the person’s experience of the illness as it
can cause a myriad of side effects that range from mild to life threatening, in and of
themselves. These can lead to an array of responses that range from mild discomfort to
symptoms of trauma (Stewart, Bielajew, Collins, Parkinson, and Tomiak, 2006, Mehnert
and Koch, 2007, and Rabin, Leventhal, and Goodin, 2004). For many, chemotherapy
changes the landscapes of their lives and is often regarded as being worse than the cancer
(Docherty, Sandelowski, and Preisser, 2006). The DSM-IV-TR includes “being
diagnosed with a life-threatening illness” as a traumatic event that can lead to the
symptoms and diagnosis of Posttraumatic Stress Disorder (PTSD) (DSM-IV-TR, 2000, p.
462). To the best of my knowledge, this is the first study that proposes to closely
examine the specific stressors that can arise from chemotherapy as it is considered
independently from cancer. Previous research has found that individuals undergoing
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chemotherapy experience changes in quality of life (e.g. Zebrack, Yi, Petersen, and Ganz,
2007, Hurria, A., Rosen, Hudis, Zuckerman, Panageas, Lachs, Witmer, van Gorp,
Fornier, D’Andrea, Moasser, Dang, Van Poznak, Hurria, and Holland, 2006, and Carver,
Smith, Petronis, and Antoni, 2006), anticipatory nausea (e.g. Montgomery, Bovbjerg,
2003, and Montgomery,Bovbjerg, 2001), cognitive impairment (e.g. Falleti, Sanfilippo,
Maruff, Weih, and Phillips, 2005, and Bender, Sereika, Berga, Vogel, Brufsky, Paraska,
and Ryan, 2006), depression and anxiety (e.g. Reddick, Nanda, Campbell, Ryman, and
Gaston-Johansson, 2005, and Deshields, Tibbs, Fan, and Taylor, 2006), and fatigue (e.g.
Jacobsen, Hann, Azzarello, Horton, Balducci, and Lyman, 1999, and Mills, Parker,
Dimsdale, Sadler, and Ancoli-Israel, 2005). None of these studies, however, have looked
at how these chemotherapy side effects have affected the realms of spirituality, sense of
self, world view, and sexuality, as this study plans to do.
What is it like when the treatment for the illness is what many consider to be the
worst part? What about effects that aren’t considered to be traumatic, but still impact
one’s life? This study will look more closely at the experiences of women who have
undergone chemotherapy for the treatment of breast cancer and will consider the full
range of experiences to better understand the effects it has on people’s lives.
Specifically, the purpose of this study is to lay the groundwork for the understanding of
the impact of chemotherapy on breast cancer survivors. However, the implications of the
findings of this study can be broadened and generalized to other cancers that have a
chemotherapy protocol as well. These findings can be translated into ways to provide
more emotional, physical, spiritual, and mental support for patients undergoing
chemotherapy and allow for a better understanding of what happens when someone
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undergoes a life-threatening treatment. While the chemotherapy experience may not be
explicitly traumatic, it is possible that it is on a spectrum that includes its own set of
psychologically distressing symptoms that need to be addressed in the field of mental
health.
Through one-to-one interviews with women who have been treated for breast
cancer, I plan to focus in-depth on what the experience of chemotherapy was like for
these women and how it changed their lives, for good, bad, or not at all. This kind of
information can lead to a better understanding of what is needed by cancer patients
before, during, and after chemotherapy. Are their mental health needs being met? Are
their relationships being strained? Has it raised questions regarding their faith? Do they
regret the decision? All of these are important factors to consider when treating a person
as a whole and should not be overlooked by the medical and mental health communities.
According to Boyatzis, the purpose of analyses of data in social work studies is to
summarize and describe the meaning and content of the answers (Anastas, 1999). The
interviews will start with an explanation from me about the purpose of the study and an
invitation to the participant to describe in as much detail as they feel comfortable, what
chemotherapy was like for them, including the context of their life when it began. The
purpose of conducting the interviews in such an open-ended manner is to allow the
participants to connect with their material in their own way and to describe the situation
in a totally subjective manner.
It is possible that questions designed to illicit a deeper response may be used in
some instances, such as “What did you think about while you were in the chair getting
chemo?” and “What was it like for your family and loved ones?” Interviews will be
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audio recorded, and I will also take notes during them noting affect and anything else of
significance. These field notes will be correlated with each interview during the
transcription process and similarities and discrepancies will be noted in the analysis. I
will analyze the data using the grounded theory method that is “explicitly designed for
‘the discovery of theory from data systematically obtained and analyzed in social
research’” (Anastas, 1999, p.61).
The research from this study will be used in my MSW thesis for the Smith
College School for Social Work where it will be presented to my peers and colleagues in
partial fulfillment of my graduation requirements. This research will be used for possible
presentation and publication and a copy of it will remain in the Smith library.
The Characteristics of the Participants
Participants in this study must be women 18 and older, fluent in English, who
have undergone chemotherapy specifically for the treatment of breast cancer. They must
be between six months and five years from the end of chemotherapy. There are no
specific exclusionary characteristics if the women fall into these categories. I would like
to have a broad range of age, race, religion, socioeconomic status, and marital status. A
sample size of 12 to 15 women is ideal.
The Recruitment Process
The recruitment will take place in Denver, Colorado and will take place through
word of mouth initially beginning through connections and associates of my mother,
herself a breast cancer survivor. Through my mother and her friends and colleagues
eligible participants will be identified and given my contact information with which to
follow-up. For participants who may be known to me, they will receive a brief
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description of the study, its requirements, and my contact information. If they chose to
contact me a phone interview will follow and at no time will I be informed of their names
or addresses. For others, they will also receive my contact information and I will also
receive theirs through our mutual contact. These interviews may happen over the phone
or in person, at the participant’s discretion. This open method of recruitment will allow
for the most diverse sample to be obtained in that a broad range of possible participants
will be notified through my mother and her contacts.
The Nature of Participation
Interviews will be expected to last no more than an hour. Participants need only
show up and be willing to have the interview tape recorded. Participants will have the
option of deciding where they would like to conduct the face-to-face interviews.
Interviews will be conducted in a private room at a local library, which I will obtain
permission to use ahead of time. If a phone interview is indicated, if I know the
participant or they are more comfortable with this format, this will be arranged in lieu of
a face-to-face interview. Phone interviews will be recorded using a recording device
designed for this purpose. Demographic data, including age, age at diagnosis, stage of
cancer, and family history of cancer, race, religion, occupation, and marital status will be
collected to ensure a broad range of experiences and ensure diversity. A form will be
provided to subjects, either through mail or email, to fill out prior to the interview, as
well as the Informed Consent form. For phone interviews these forms will not be
required, instead a copy of the Informed Consent will be provided to them prior to the
interview by our mutual contact. This will also include a stamped envelope addressed to
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myself. Verbal consent also will be obtained over the phone and demographic data will
be collected verbally. All interviews will be transcribed by myself.
Risks of Participation
The primary risk of participating in this study is that interviewees may experience
some degree of emotional stress or trigger. Discussing an experience like chemotherapy
can be upsetting and make the participant feel vulnerable. These risks will be discussed
openly and participants reassured that they may stop the interview at any time. The
women will be provided with a list of local mental health professionals, clinics, and
hotlines in the event that they feel they need to talk to someone following the interview.
They will also be reassured that all information gathered will be held in confidence by
myself. My thesis advisor will only have access to their information once all identifying
information has been removed. Names will not be used in the study and identifying
characteristics will be minimal.
Benefits of Participation
A primary benefit of participating in this study will be the participant’s
knowledge that her experience and sharing of it can potentially lead to a better
understanding and system of care for others who have to undergo similarly invasive and
traumatizing protocols. Additionally, the chance to process the experience and share it
with another may provide new understanding about it for the participant and may help her
to think of it in previously unconsidered terms.
Informed Consent Procedures
Informed Consent forms will be mailed to participants at least a week before the
interview is to take place as a way to give participants a chance to read it and think of any
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questions or concerns ahead of time. This will include a stamped return envelope if they
chose to mail it back to me rather than bring it to the interview. I will bring extra copies
as well in the event that a participant forgets to bring hers. I will collect a signed copy
from each participant and also provide a blank copy for each subject to retain for her own
records. In the case of a phone interview, the Informed Consent form need to have been
returned to me prior to the interview, by mail. Two copies of the Informed Consent will
be provided to them prior to the interview by our mutual contact, one to sign and return,
and one to keep for their records. I will also include a stamped envelope addressed to
myself in which to return the consent form.
Precautions Taken to Safeguard Confidentiality and Identifiable Information
Confidentiality will be protected in this study by not including any personally
identifying information in the interviews beyond previously mentioned demographic
data, and keeping responses in a locked box. I will blind all data by referring to subjects
by a randomly assigned number instead of using their name to track participation and
data collection. Data used in quotations and vignettes will also be disguised. Any
questions may be skipped and not answered and participants may drop out of the study at
any time during the data collection process or after, up until April 30, 2008. All
information will be shared will my thesis advisor only after all identifying characteristics
have been removed or disguised. All data collected, including notes, transcripts, tapes,
etc., will be kept for 3 years in a secure location, as per federal guidelines. If materials
are needed longer they will continue to be stored securely and will be securely destroyed
when no longer needed. I will make available the names and numbers of organizations
offering support to cancer survivors as well as the names and numbers of practicing
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clinicians in their areas. All areas of concern are addressed in the Informed Consent and
any additional questions or concerns that may arise may be addressed to me via phone or
email at any time.
Investigator’s Signature:___Amy Willson______________Date:__1/26/08_______
Advisor’s Signature:_______________________________Date:______________
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February 27, 2008
Amy Willson
Dear Amy,
Your second set of revisions has been reviewed and all is now in order. We are therefore
glad to give final approval to your study.
Please note the following requirements:
Consent Forms: All subjects should be given a copy of the consent form.
Maintaining Data: You must retain signed consent documents for at least three (3)
years past completion of the research activity.
In addition, these requirements may also be applicable:
Amendments: If you wish to change any aspect of the study (such as design,
procedures, consent forms or subject population), please submit these changes to the
Committee.
Renewal: You are required to apply for renewal of approval every year for as long as the
study is active.
Completion: You are required to notify the Chair of the Human Subjects Review
Committee when your study is completed (data collection finished). This requirement is
met by completion of the thesis project during the Third Summer.
Good luck with your project.
Sincerely,

Ann Hartman, D.S.W.
Chair, Human Subjects Review Committee
CC: Jill Clemence, Research Advisor
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Appendix B
Informed Consent Form
Dear Participant,
My name is Amy Willson. I am conducting a research study of breast cancer
survivors to learn more about the experience of chemotherapy and its effect on identity,
self, worldview, and other areas of change. The purpose of this is to learn more about
possible additional supports that could be put into place for such a population. The study
is being conducted for my thesis in the Master of Social Work program at the Smith
College School for Social Work and may be presented and used for publication.
I am interested in exploring the experiences and life changes, if any, experienced
by women who have been treated with a chemotherapy protocol for breast cancer. You
are being asked to participate in this study if (a) you are over the age of eighteen (18), (b)
you have had chemotherapy for breast cancer and (c) you are between six (6) months and
five (5) years past treatment. As a participant in this study you will asked to participate in
a face-to-face interview, or a phone interview. Face-to-face interviews will be conducted
in a private room of a local library, to be arranged ahead of time by me, to ensure
confidentiality. Questions will focus on your experience while undergoing
chemotherapy. The interview will take between 45 to 60 minutes. Interviews will be
audio recorded and tapes will be transcribed and coded numerically by myself to ensure
your confidentiality. Tapes will be destroyed after three (3) years, along with all other
study material. All interviews will be transcribed by myself. You will also be asked to
fill out a brief demographic questionnaire at the beginning of the interview to collect
background data for the study.
The potential risks of participating in this study are the possibility that you might
feel strong or uncomfortable emotions while talking about your experiences. In case you
feel the need for additional support after participating in this study, you will be given a
list of resources for mental health services in your area.
Your participation in this study is completely voluntary. You will receive no
financial benefit for your participation in this study. You may benefit from knowing that
you have contributed to the knowledge of mental health treatment of cancer patients
undergoing chemotherapy. It is my hope that this study will help social workers have a
better understanding of how to work more effectively with those diagnosed with breast
cancer. You may also benefit from being able to tell your story and having your
perspective heard.
Strict confidentiality will be maintained, as consistent with Federal regulations
and the mandates of the social work profession. Coding the information and storing the
data in a locked file for a minimum of 3 years will protect confidentiality. Should I need
the materials beyond the 3 year period they will continue to be kept in a secure location
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and will be destroyed when no longer needed. Your identity will be protected, as names
will be changed in the analysis of the data. Your name will never be associated with the
information you provide in the questionnaire or the interview, but your demographic
information will be used. The data may be used in other educational activities as well as
in the preparation for my Master’s thesis and may been seen by my thesis advisor once
identifying information has been removed. When my thesis is presented the data will be
presented as a whole and when brief illustrative quotes or vignettes are used they will be
carefully disguised. Any concerns regarding confidentiality may be further discussed
with me before the interview commences.
This study is completely voluntary. You are free to refuse to answer specific
questions and to withdraw from the interview at any time. If you decide to withdraw, all
data describing you will be immediately destroyed. If you decide to withdraw wholly
from the study you may do so by notifying me by April 30, 2008. You may reach me at
any time via phone or email at the number below, to discuss concerns or questions and
you may contact the Smith College School for Social Work Human Subjects Review
Committee at 413-585-7974.
YOUR SIGNATURE INDICATES THAT YOU HAVE READ AND
UNDERSTAND THE ABOVE INFORMATION AND THAT YOU HAVE HAD
THE OPPORTUNITY TO ASK QUESTIONS ABOUT THE STUDY, YOUR
PARTICIPATION, AND YOUR RIGHTS AND THAT YOU AGREE TO
PARTICIPATE IN THE STUDY.
SIGNATURE OF PARTICIPANT

SIGNATURE OF RESEARCHER

____________________________
DATE

____________________________
DATE

If you have any questions or wish to withdraw your consent, please contact: Amy
Willson. Please keep a copy of this consent for your own records.

Sincerely,

Amy Willson
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Appendix C
Demographic Information Form
Birthdate and age:
Date diagnosed with breast cancer:
Stage of cancer with which you were diagnosed:
Family history of cancer:
Race/ethnicity:
Occupation:
Marital status:
Religious affiliation:

(for researcher to assign) Number:
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Appendix D
Interview Guide
1) What was going on in your life when you were receiving chemotherapy? What
was the context? This may include other treatments you may have previously
received.
2) When were you diagnosed? What factors contributed to your decision to undergo
chemotherapy? Family? Family history? Friends? What did your doctor tell you
about it and how did they present it to you?
3) How did you explain the decision to yourself? Your family?
4) Who supported you during the process? Sat with you? Drove you?
5) What was your biggest concern before the protocol began? During? After?
6) What did you think about while you were receiving the chemotherapy? (For
those who received it via I.V.) Did you visualize what was happening in your
body? If so, how?
7) What side effects, if any, did you experience? How well did you tolerate it? What
was that like for you emotionally? Physically?
8) Did you decide to continue/not continue with chemotherapy? Why or why not?
9) What changed for you during the treatment emotionally? Mentally? Physically?
Were there any positive changes in your life? Negative changes? What’s
different now? What’s the same?
10) Did it affect your worldview? Spirituality? Relationships? Sense of self?
11) What would it have been like if you hadn’t decided to get chemotherapy?
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12) Do you feel your reaction was due to the chemotherapy or to the diagnosis of
cancer itself, or both?
13) Is there anything you would like to add? Any questions for me?
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